| 1 | MG-TCCA: Tensor Canonical Correlation Analysis Across Multiple Groups | 3.0 | 1 | Citations (PDF) |
| 2 | Traumatic Brain Injury and Alzheimer’s Disease Biomarkers: A Systematic Review of Findings from Amyloid and Tau Positron Emission Tomography | 3.6 | 2 | Citations (PDF) |
| 3 | Comprehensive characterization of the transcriptional landscape in Alzheimer’s disease (AD) brains | 10.9 | 7 | Citations (PDF) |
| 4 | LD‐informed deep learning for Alzheimer's gene loci detection using WGS data | 4.8 | 4 | Citations (PDF) |
| 5 | Cell-specific transcriptional signatures of vascular cells in Alzheimer’s disease: perspectives, pathways, and therapeutic directions | 14.1 | 16 | Citations (PDF) |
| 6 | Dynamic diffusion-weighted imaging of intracranial cardiac impulse propagation along arteries to arterioles in the aging brain | 4.7 | 11 | Citations (PDF) |
| 7 | Longitudinal non-linear changes in the microstructure of the hippocampal subfields in older adults | 3.4 | 2 | Citations (PDF) |
| 8 | Deep fusion of incomplete multi-omic data for molecular mechanism of Alzheimer’s disease | 3.4 | 1 | Citations (PDF) |
| 9 | miR-129-5p as a biomarker for pathology and cognitive decline in Alzheimer’s disease | 6.5 | 27 | Citations (PDF) |
| 10 | Distance-weighted Sinkhorn loss for Alzheimer’s disease classification | 3.5 | 4 | Citations (PDF) |
| 11 | Does the Cognitive Change Index Predict Future Cognitive and Clinical Decline? Longitudinal Analysis in a Demographically Diverse Cohort | 2.6 | 6 | Citations (PDF) |
| 12 | Prediction of cognitive decline in older breast cancer survivors: the Thinking and Living with Cancer study | 2.9 | 9 | Citations (PDF) |
| 13 | Association of Heart Failure With Cognitive Decline and Development of Mild Cognitive Impairment and Dementia | 1.4 | 8 | Citations (PDF) |
| 14 | Black Americans' perceptions of Alzheimer's disease, a healthy brain, and strategies for brain health promotion | 1.3 | 3 | Citations (PDF) |
| 15 | Deep Trans-Omic Network Fusion for Molecular Mechanism of Alzheimer’s Disease | 2.6 | 2 | Citations (PDF) |
| 16 | Interpretable deep clustering survival machines for Alzheimer’s disease subtype discovery | 10.6 | 8 | Citations (PDF) |
| 17 | Gliovascular transcriptional perturbations in Alzheimer’s disease reveal molecular mechanisms of blood brain barrier dysfunction | 13.7 | 43 | Citations (PDF) |
| 18 | Brain‐age prediction: Systematic evaluation of site effects, and sample age range and size | 3.5 | 42 | Citations (PDF) |
| 19 | Multiparameter cortical surface morphology in former amateur contact sport athletes | 2.8 | 4 | Citations (PDF) |
| 20 | Coupled pulsatile vascular and paravascular fluid dynamics in the human brain | 5.3 | 22 | Citations (PDF) |
| 21 | miR‐133b as a potential regulator of a synaptic NPTX2 protein in Alzheimer's disease | 3.7 | 10 | Citations (PDF) |
| 22 | CYP1B1-RMDN2 Alzheimer’s disease endophenotype locus identified for cerebral tau PET | 13.7 | 12 | Citations (PDF) |
| 23 | Referral Sources Across Racial and Ethnic Groups at Alzheimer’s Disease Research Centers | 2.6 | 4 | Citations (PDF) |
| 24 | Alzheimer Disease Blood-Based Biomarkers: Translation from Research into Clinical Use | 1.1 | 0 | Citations (PDF) |
| 25 | Genetic and clinical correlates of two neuroanatomical AI dimensions in the Alzheimer’s disease continuum | 5.2 | 15 | Citations (PDF) |
| 26 | Genomic analysis of intracranial and subcortical brain volumes yields polygenic scores accounting for variation across ancestries | 25.2 | 25 | Citations (PDF) |
| 27 | Pathway enrichment in genome‐wide analysis of longitudinal Alzheimer's disease biomarker endophenotypes | 0.5 | 5 | Citations (PDF) |
| 28 | Deciphering the tissue-specific functional effect of Alzheimer risk SNPs with deep genome annotation | 3.6 | 2 | Citations (PDF) |
| 29 | Association of amyloid and cardiovascular risk with cognition: Findings from KBASE | 0.5 | 6 | Citations (PDF) |
| 30 | Genetic variants for Alzheimer's disease and comorbid conditions | 2.6 | 2 | Citations (PDF) |
| 31 | Development and psychometric evaluation of the Test of Practical Judgment alternate form (Form B) | 1.9 | 2 | Citations (PDF) |
| 32 | Integrative Co-methylation Network Analysis Identifies Novel DNA Methylation Signatures and Their Target Genes in Alzheimer’s Disease | 5.4 | 20 | Citations (PDF) |
| 33 | Integrative analysis of multi-omics and imaging data with incorporation of biological information via structural Bayesian factor analysis | 6.6 | 13 | Citations (PDF) |
| 34 | Aberrant GAP43 Gene Expression Is Alzheimer Disease Pathology‐Specific | 6.6 | 1 | Citations (PDF) |
| 35 | Genetic Variants Associated with Longitudinal Cognitive Performance in Older Breast Cancer Patients and Controls | 3.8 | 5 | Citations (PDF) |
| 36 | Longitudinal Associations Between Blood Biomarkers and White Matter MRI in Sport-Related Concussion | 1.0 | 13 | Citations (PDF) |
| 37 | Fused multi-modal similarity network as prior in guiding brain imaging genetic association | 1.7 | 0 | Citations (PDF) |
| 38 | A protein panel in cerebrospinal fluid for diagnostic and predictive assessment of Alzheimer’s disease | 12.5 | 61 | Citations (PDF) |
| 39 | Genome-Wide Association Analysis across Endophenotypes in Alzheimer’s Disease: Main Effects and Disease Stage-Specific Interactions | 2.5 | 3 | Citations (PDF) |
| 40 | An interpretable Alzheimer’s disease oligogenic risk score informed by neuroimaging biomarkers improves risk prediction and stratification | 3.9 | 8 | Citations (PDF) |
| 41 | Gene Expression Alterations in Peripheral Blood Following Sport-Related Concussion in a Prospective Cohort of Collegiate Athletes: A Concussion Assessment, Research and Education (CARE) Consortium Study | 6.2 | 4 | Citations (PDF) |
| 42 | Edge time series components of functional connectivity and cognitive function in Alzheimer’s disease | 2.1 | 9 | Citations (PDF) |
| 43 | Blood biomarkers of neuronal injury in paediatric cerebral malaria and severe malarial anaemia | 3.6 | 12 | Citations (PDF) |
| 44 | Genomic loci influence patterns of structural covariance in the human brain | 7.5 | 30 | Citations (PDF) |
| 45 | Greater male than female variability in regional brain structure across the lifespan | 3.5 | 126 | Citations (PDF) |
| 46 | Cortical thickness across the lifespan: Data from 17,075 healthy individuals aged 3–90 years | 3.5 | 285 | Citations (PDF) |
| 47 | Subcortical volumes across the lifespan: Data from 18,605 healthy individuals aged 3–90 years | 3.5 | 155 | Citations (PDF) |
| 48 | Re-evaluation of psychometric evidence and update of normative data for the Test of Practical Judgment | 2.7 | 6 | Citations (PDF) |
| 49 | Using the Alzheimer's Disease Neuroimaging Initiative to improve early detection, diagnosis, and treatment of Alzheimer's disease | 0.5 | 170 | Citations (PDF) |
| 50 | Social Networks and Cognitive Reserve: Network Structure Moderates the Association Between Amygdalar Volume and Cognitive Outcomes | 2.7 | 52 | Citations (PDF) |
| 51 | Multi-task learning based structured sparse canonical correlation analysis for brain imaging genetics | 10.6 | 27 | Citations (PDF) |
| 52 | Integrative metabolomics‐genomics approach reveals key metabolic pathways and regulators of Alzheimer's disease | 0.5 | 177 | Citations (PDF) |
| 53 | Deep learning-based identification of genetic variants: application to Alzheimer’s disease classification | 6.6 | 70 | Citations (PDF) |
| 54 | Cognitively stimulating environments and cognitive reserve: the case of personal social networks | 3.4 | 33 | Citations (PDF) |
| 55 | Visit-to-Visit Blood Pressure Variability and Longitudinal Tau Accumulation in Older Adults | 6.6 | 34 | Citations (PDF) |
| 56 | Genome-wide association study of brain arteriolosclerosis | 4.7 | 4 | Citations (PDF) |
| 57 | Estradiol treatment in young postmenopausal women with self‐reported cognitive complaints: Effects on cholinergic‐mediated cognitive performance | 1.7 | 8 | Citations (PDF) |
| 58 | Characterizing Heterogeneity in Neuroimaging, Cognition, Clinical Symptoms, and Genetics Among Patients With Late-Life Depression | 12.4 | 142 | Citations (PDF) |
| 59 | Associations between longitudinal changes in sleep disturbance and depressive and anxiety symptoms during theCOVID‐19 virus pandemic among older women with and without breast cancer in the thinking and living with breast cancer study | 2.6 | 11 | Citations (PDF) |
| 60 | Measuring Subjective Cognitive Decline in Older Adults: Harmonization Between the Cognitive Change Index and the Measurement of Everyday Cognition Instruments | 2.6 | 4 | Citations (PDF) |
| 61 | Manifestations of Alzheimer’s disease genetic risk in the blood are evident in a multiomic analysis in healthy adults aged 18 to 90 | 3.4 | 27 | Citations (PDF) |
| 62 | Integrative analysis of eQTL and GWAS summary statistics reveals transcriptomic alteration in Alzheimer brains | 1.7 | 5 | Citations (PDF) |
| 63 | Association of the top 20 Alzheimer's disease risk genes with [18F]flortaucipir PET | 2.4 | 9 | Citations (PDF) |
| 64 | Multimodal MRI examination of structural and functional brain changes in older women with breast cancer in the first year of antiestrogen hormonal therapy | 2.3 | 21 | Citations (PDF) |
| 65 | Structural connectivity mapping in human hippocampal-subfields using super-resolution hybrid diffusion imaging: a feasibility study | 2.1 | 2 | Citations (PDF) |
| 66 | Sex differences in the genetic architecture of cognitive resilience to Alzheimer’s diseaseBrain, 2022, 145, 2541-2554 | 8.4 | 103 | Citations (PDF) |
| 67 | Autosomal dominant and sporadic late onset Alzheimer's disease share a commonin vivopathophysiologyBrain, 2022, 145, 3594-3607 | 8.4 | 60 | Citations (PDF) |
| 68 | Association of markers of tumor aggressivity and cognition in women with breast cancer before adjuvant treatment: The Thinking and Living with Cancer Study | 2.3 | 13 | Citations (PDF) |
| 69 | Glucose metabolism patterns: A potential index to characterize brain ageing and predict high conversion risk into cognitive impairment | 4.6 | 14 | Citations (PDF) |
| 70 | Immunity gene IFITM3 variant: Relation to cognition and Alzheimer's disease pathology | 2.4 | 7 | Citations (PDF) |
| 71 | Comprehensive genetic analysis of the human lipidome identifies loci associated with lipid homeostasis with links to coronary artery disease | 13.7 | 101 | Citations (PDF) |
| 72 | An IL1RL1 genetic variant lowers soluble ST2 levels and the risk effects of APOE-ε4 in female patients with Alzheimer’s disease | 14.5 | 47 | Citations (PDF) |
| 73 | Mining High-Level Imaging Genetic Associations via Clustering AD Candidate Variants with Similar Brain Association Patterns | 2.5 | 3 | Citations (PDF) |
| 74 | Identifying genetic markers enriched by brain imaging endophenotypes in Alzheimer’s disease | 1.7 | 5 | Citations (PDF) |
| 75 | Genome-wide meta-analyses reveal novel loci for verbal short-term memory and learning | 7.8 | 19 | Citations (PDF) |
| 76 | Multi-task deep autoencoder to predict Alzheimer’s disease progression using temporal DNA methylation data in peripheral blood | 3.9 | 26 | Citations (PDF) |
| 77 | Multi-Omic analyses characterize the ceramide/sphingomyelin pathway as a therapeutic target in Alzheimer’s disease | 4.4 | 95 | Citations (PDF) |
| 78 | Myelin repair in Alzheimer’s disease: a review of biological pathways and potential therapeutics | 12.5 | 38 | Citations (PDF) |
| 79 | NEUROLOGICAL CORRELATES OF SOCIAL BONDING AND BRIDGING | 0.1 | 0 | Citations (PDF) |
| 80 | UNRAVELING THE AMBIGUITY BETWEEN COGNITION AND DEPRESSION: A LONGITUDINAL ANALYSIS OF OLDER ADULTS | 0.1 | 1 | Citations (PDF) |
| 81 | Altered cerebral blood flow in older adults with Alzheimer’s disease: a systematic review | 2.1 | 41 | Citations (PDF) |
| 82 | A novel deep learning method for predictive modeling of microbiome data | 6.6 | 47 | Citations (PDF) |
| 83 | Late-Life Depression Is Associated With Reduced Cortical Amyloid Burden: Findings From the Alzheimer’s Disease Neuroimaging Initiative Depression Project | 5.4 | 77 | Citations (PDF) |
| 84 | Testing influences of APOE and BDNF genes and heart failure on cognitive function | 2.1 | 6 | Citations (PDF) |
| 85 | Neuroimaging in infants with prenatal opioid exposure: Current evidence, recent developments and targets for future research | 1.5 | 27 | Citations (PDF) |
| 86 | Tau-related white-matter alterations along spatially selective pathways | 4.4 | 51 | Citations (PDF) |
| 87 | Novel Alzheimer Disease Risk Loci and Pathways in African American Individuals Using the African Genome Resources Panel | 17.6 | 269 | Citations (PDF) |
| 88 | A Systematic Review of Delirium Biomarkers and Their Alignment with the
NIA‐AA
Research Framework | 2.9 | 25 | Citations (PDF) |
| 89 | Multi-Task Sparse Canonical Correlation Analysis with Application to Multi-Modal Brain Imaging Genetics | 3.0 | 43 | Citations (PDF) |
| 90 | Deficit Accumulation Frailty Trajectories of Older Breast Cancer Survivors and Non-Cancer Controls: The Thinking and Living With Cancer Study | 4.6 | 53 | Citations (PDF) |
| 91 | Pattern and degree of individual brain atrophy predicts dementia onset in dominantly inherited Alzheimer's disease | 2.4 | 9 | Citations (PDF) |
| 92 | Differential patterns of gray matter volumes and associated gene expression profiles in cognitively-defined Alzheimer’s disease subgroups | 3.3 | 27 | Citations (PDF) |
| 93 | Stability of Subjective Executive Functioning in Older Adults with aMCI and Subjective Cognitive Decline | 0.4 | 10 | Citations (PDF) |
| 94 | Longitudinal cognitive performance of Alzheimer's disease neuropathological subtypes | 4.8 | 14 | Citations (PDF) |
| 95 | Serum metabolites associated with brain amyloid beta deposition, cognition and dementia progression | 3.6 | 46 | Citations (PDF) |
| 96 | Temporal stability of the ventral attention network and general cognition along the Alzheimer’s disease spectrum | 3.3 | 12 | Citations (PDF) |
| 97 | Detection of β-amyloid positivity in Alzheimer’s Disease Neuroimaging Initiative participants with demographics, cognition, MRI and plasma biomarkers | 3.6 | 81 | Citations (PDF) |
| 98 | Assessment of Blood Biomarker Profile After Acute Concussion During Combative Training Among US Military Cadets | 6.6 | 36 | Citations (PDF) |
| 99 | The Impact of Amyloid Burden and
APOE
on Rates of Cognitive Impairment in Late Life Depression | 2.6 | 22 | Citations (PDF) |
| 100 | Response to Dekker, Stege, and Versteeg | 4.6 | 0 | Citations (PDF) |
| 101 | Longitudinal Associations of Blood Phosphorylated Tau181 and Neurofilament Light Chain With Neurodegeneration in Alzheimer Disease | 17.6 | 269 | Citations (PDF) |
| 102 | Effect of chemotherapy on default mode network connectivity in older women with breast cancer | 2.1 | 16 | Citations (PDF) |
| 103 | WEVar: a novel statistical learning framework for predicting noncoding regulatory variants | 6.6 | 9 | Citations (PDF) |
| 104 | Optimizing differential identifiability improves connectome predictive modeling of cognitive deficits from functional connectivity in Alzheimer's disease | 3.5 | 33 | Citations (PDF) |
| 105 | Integrative-omics for discovery of network-level disease biomarkers: a case study in Alzheimer’s disease | 6.6 | 17 | Citations (PDF) |
| 106 | Rare CASP6N73T variant associated with hippocampal volume exhibits decreased proteolytic activity, synaptic transmission defect, and neurodegeneration | 3.4 | 12 | Citations (PDF) |
| 107 | Loneliness and mental health during the COVID‐19 pandemic in older breast cancer survivors and noncancer controls | 4.0 | 76 | Citations (PDF) |
| 108 | The human connectome in Alzheimer disease — relationship to biomarkers and genetics | 28.6 | 256 | Citations (PDF) |
| 109 | Applying a Life Course Biological Age Framework to Improving the Care of Individuals With Adult Cancers | 14.3 | 50 | Citations (PDF) |
| 110 | Predictability of polygenic risk score for progression to dementia and its interaction with APOE ε4 in mild cognitive impairment | 12.5 | 21 | Citations (PDF) |
| 111 | Apolipoprotein E ɛ4–related effects on cognition are limited to the Alzheimer’s disease spectrum | 4.6 | 9 | Citations (PDF) |
| 112 | Tau deposition and structural connectivity demonstrate differential association patterns with neurocognitive tests | 2.1 | 6 | Citations (PDF) |
| 113 | Medical care disruptions during the first six months of the COVID-19 pandemic: the experience of older breast cancer survivors | 2.3 | 11 | Citations (PDF) |
| 114 | Differential trajectories of hypometabolism across cognitively-defined Alzheimer’s disease subgroups | 3.3 | 17 | Citations (PDF) |
| 115 | Head injury is associated with tau deposition on PET in MCI and AD patients | 2.4 | 12 | Citations (PDF) |
| 116 | Protective Effects of APOE ε2 Genotype on Cognition in Older Breast Cancer Survivors: The Thinking and Living With Cancer Study | 2.9 | 14 | Citations (PDF) |
| 117 | Longitudinal Accumulation of Cerebral Microhemorrhages in Dominantly Inherited Alzheimer Disease | 1.0 | 25 | Citations (PDF) |
| 118 | Tau‐Atrophy Variability Reveals Phenotypic Heterogeneity in Alzheimer's Disease | 6.6 | 45 | Citations (PDF) |
| 119 | BMI1 is associated with CSF amyloid-β and rates of cognitive decline in Alzheimer’s disease | 6.5 | 7 | Citations (PDF) |
| 120 | Association of peripheral blood DNA methylation level with Alzheimer’s disease progression | 3.9 | 65 | Citations (PDF) |
| 121 | Dysregulated expression levels of APH1B in peripheral blood are associated with brain atrophy and amyloid-β deposition in Alzheimer’s disease | 6.5 | 33 | Citations (PDF) |
| 122 | Impact of taxane-based chemotherapy among older women with breast cancer on cognition and quality of life: a longitudinal pooled analysis | 2.3 | 3 | Citations (PDF) |
| 123 | A missense variant in SHARPIN mediates Alzheimer’s disease-specific brain damages | 5.2 | 20 | Citations (PDF) |
| 124 | A deep learning framework identifies dimensional representations of Alzheimer’s Disease from brain structure | 13.7 | 98 | Citations (PDF) |
| 125 | Prescribing cholinesterase inhibitors in mild cognitive impairment—Observations from the Alzheimer's Disease Neuroimaging Initiative | 4.8 | 9 | Citations (PDF) |
| 126 | Longitudinal Early‐onset Alzheimer’s Disease Study (LEADS) genetic screening: Initial results | 0.5 | 0 | Citations (PDF) |
| 127 | Association of Plasma Tau With Mortality and Long-term Neurocognitive Impairment in Survivors of Pediatric Cerebral Malaria and Severe Malarial Anemia | 6.6 | 31 | Citations (PDF) |
| 128 | FDG-PET Brain Metabolic Changes in A-/T-/N-Early- and Late-onset Cognitively Impaired Subjects (1871) | 1.0 | 0 | Citations (PDF) |
| 129 | Elevated Cerebrospinal Fluid Tau Protein Concentrations on Admission Are Associated With Long-term Neurologic and Cognitive Impairment in Ugandan Children With Cerebral Malaria | 5.2 | 36 | Citations (PDF) |
| 130 | Resting-State fMRI Metrics in Acute Sport-Related Concussion and Their Association with Clinical Recovery: A Study from the NCAA-DOD CARE Consortium | 3.6 | 72 | Citations (PDF) |
| 131 | Effects of chemotherapy on aging white matter microstructure: A longitudinal diffusion tensor imaging study | 1.8 | 31 | Citations (PDF) |
| 132 | Symptom burden among older breast cancer survivors: The Thinking and Living With Cancer (TLC) study | 4.0 | 79 | Citations (PDF) |
| 133 | Regional imaging genetic enrichment analysis | 4.7 | 22 | Citations (PDF) |
| 134 | Multi-modal neuroimaging feature selection with consistent metric constraint for diagnosis of Alzheimer's disease | 10.6 | 188 | Citations (PDF) |
| 135 | Dysregulated Fc gamma receptor–mediated phagocytosis pathway in Alzheimer's disease: network-based gene expression analysis | 3.4 | 43 | Citations (PDF) |
| 136 | S32. ARE SELECTIVE ESTROGEN RECEPTOR BETA AGONISTS POTENTIAL THERAPEUTICS FOR SCHIZOPHRENIA? | 3.9 | 2 | Citations (PDF) |
| 137 | Association of blood-based transcriptional risk scores with biomarkers for Alzheimer disease | 2.8 | 23 | Citations (PDF) |
| 138 | Genetic correlations and genome-wide associations of cortical structure in general population samples of 22,824 adults | 13.7 | 95 | Citations (PDF) |
| 139 | Higher CSF sTREM2 attenuates ApoE4-related risk for cognitive decline and neurodegeneration | 14.1 | 73 | Citations (PDF) |
| 140 | Volumetric GWAS of medial temporal lobe structures identifies an ERC1 locus using ADNI high-resolution T2-weighted MRI data | 3.4 | 8 | Citations (PDF) |
| 141 | Identifying diagnosis-specific genotype–phenotype associations via joint multitask sparse canonical correlation analysis and classification | 4.7 | 37 | Citations (PDF) |
| 142 | Longitudinal white-matter abnormalities in sports-related concussion | 1.0 | 75 | Citations (PDF) |
| 143 | Identification of functionally connected multi-omic biomarkers for Alzheimer’s disease using modularity-constrained Lasso | 2.3 | 11 | Citations (PDF) |
| 144 | Differential Effects of Pergolide and Bromocriptine on Working Memory Performance and Brain Activation after Mild Traumatic Brain Injury | 3.6 | 3 | Citations (PDF) |
| 145 | Cognitive biomarker prioritization in Alzheimer’s Disease using brain morphometric data | 3.1 | 8 | Citations (PDF) |
| 146 | Metabolic Network Analysis Reveals Altered Bile Acid Synthesis and Metabolism in Alzheimer’s Disease | 6.6 | 181 | Citations (PDF) |
| 147 | Concordant peripheral lipidome signatures in two large clinical studies of Alzheimer’s disease | 13.7 | 140 | Citations (PDF) |
| 148 | A telescope GWAS analysis strategy, based on SNPs-genes-pathways ensamble and on multivariate algorithms, to characterize late onset Alzheimer’s disease | 3.4 | 18 | Citations (PDF) |
| 149 | Neurodegenerative changes in early- and late-onset cognitive impairment with and without brain amyloidosis | 6.5 | 26 | Citations (PDF) |
| 150 | Broad phenotype of cysteine-altering
NOTCH3
variants in UK Biobank | 1.0 | 77 | Citations (PDF) |
| 151 | Cognitive complaints are associated with smaller right medial temporal gray-matter volume in younger postmenopausal women | 2.4 | 17 | Citations (PDF) |
| 152 | Genetic variants and functional pathways associated with resilience to Alzheimer’s diseaseBrain, 2020, 143, 2561-2575 | 8.4 | 140 | Citations (PDF) |
| 153 | Development and validation of language and visuospatial composite scores in ADNI | 4.8 | 72 | Citations (PDF) |
| 154 | Image‐based modeling of biomechanical factors for risk assessment of developing periventricular white matter hyperintensities | 0.5 | 0 | Citations (PDF) |
| 155 | Genetic associations with brain amyloidosis | 0.5 | 0 | Citations (PDF) |
| 156 | Sex differences in genetic predictors of resilience to Alzheimer’s disease | 0.5 | 0 | Citations (PDF) |
| 157 | Development and validation of composite scores for language and visuospatial functioning in ADNI | 0.5 | 1 | Citations (PDF) |
| 158 | The formation of the advisory group on risk evaluation education for dementia | 0.5 | 2 | Citations (PDF) |
| 159 | A network‐based, multi‐omics atlas for target identification and prioritization in Alzheimer’s disease | 0.5 | 1 | Citations (PDF) |
| 160 | Serum metabolome informs neuroimaging biomarkers for Alzheimer’s disease | 0.5 | 1 | Citations (PDF) |
| 161 | Genome‐wide study of the human lipidome and links to Alzheimer’s disease risk | 0.5 | 2 | Citations (PDF) |
| 162 | Integrative metabolomics‐genomics approach reveals that pathways related to the metabolism of acylcarnitines and amines are new potential targets of Alzheimer’s disease | 0.5 | 1 | Citations (PDF) |
| 163 | Cognitive decline and conversion to MCI and dementia in heart failure: A 12‐year follow‐up study | 0.5 | 0 | Citations (PDF) |
| 164 | Transcriptomic profiles underlying functional brain networks at different stages of Alzheimer’s disease | 0.5 | 2 | Citations (PDF) |
| 165 | Genome‐wide analysis of longitudinal Alzheimer’s disease biomarker endophenotypes | 0.5 | 0 | Citations (PDF) |
| 166 | Protein‐protein interaction networks of genes associated with different cognitively defined subtypes of late‐onset Alzheimer's disease in five white populations identify novel candidate genes | 0.5 | 0 | Citations (PDF) |
| 167 | Serum triglycerides in Alzheimer disease | 1.0 | 109 | Citations (PDF) |
| 168 | Novel Markers of Angiogenesis in the Setting of Cognitive Impairment and Dementia | 2.6 | 24 | Citations (PDF) |
| 169 | Spread of pathological tau proteins through communicating neurons in human Alzheimer’s disease | 13.7 | 496 | Citations (PDF) |
| 170 | Association Between Common Variants in RBFOX1, an RNA-Binding Protein, and Brain Amyloidosis in Early and Preclinical Alzheimer Disease | 17.6 | 89 | Citations (PDF) |
| 171 | Harnessing peripheral DNA methylation differences in the Alzheimer’s Disease Neuroimaging Initiative (ADNI) to reveal novel biomarkers of disease | 3.9 | 95 | Citations (PDF) |
| 172 | Imaging genomics discovery of a new risk variant for Alzheimer's disease in the postsynaptic
SHARPIN
gene | 3.5 | 21 | Citations (PDF) |
| 173 | Serum neurofilament light chain levels are associated with white matter integrity in autosomal dominant Alzheimer's disease | 5.1 | 56 | Citations (PDF) |
| 174 | Cognitive function prior to systemic therapy and subsequent well‐being in older breast cancer survivors: Longitudinal findings from the Thinking and Living with Cancer Study | 3.0 | 17 | Citations (PDF) |
| 175 | The genetic architecture of the human cerebral cortex | 36.2 | 778 | Citations (PDF) |
| 176 | The Association Between Persistent White-Matter Abnormalities and Repeat Injury After Sport-Related Concussion | 2.3 | 26 | Citations (PDF) |
| 177 | Sex and APOE ε4 genotype modify the Alzheimer’s disease serum metabolome | 13.7 | 195 | Citations (PDF) |
| 178 | Systems modeling of white matter microstructural abnormalities in Alzheimer's disease | 3.3 | 18 | Citations (PDF) |
| 179 | Association of Blood Biomarkers With Acute Sport-Related Concussion in Collegiate Athletes | 6.6 | 170 | Citations (PDF) |
| 180 | The characterisation of subjective cognitive decline | 17.9 | 1,242 | Citations (PDF) |
| 181 | MicroRNA-298 reduces levels of human amyloid-β precursor protein (APP), β-site APP-converting enzyme 1 (BACE1) and specific tau protein moieties | 7.8 | 99 | Citations (PDF) |
| 182 | Detecting genetic associations with brain imaging phenotypes in Alzheimer’s disease via a novel structured SCCA approach | 10.6 | 87 | Citations (PDF) |
| 183 | Visual contrast sensitivity is associated with the presence of cerebral amyloid and tau deposition | 3.6 | 49 | Citations (PDF) |
| 184 | Differential co-expression analysis reveals early stage transcriptomic decoupling in alzheimer’s disease | 1.7 | 6 | Citations (PDF) |
| 185 | Resting state functional MRI in infants with prenatal opioid exposure—a pilot study | 2.1 | 44 | Citations (PDF) |
| 186 | Associating Multi-Modal Brain Imaging Phenotypes and Genetic Risk Factors via a Dirty Multi-Task Learning Method | 7.8 | 43 | Citations (PDF) |
| 187 | Deep learning detection of informative features in tau PET for Alzheimer’s disease classification | 3.0 | 77 | Citations (PDF) |
| 188 | Brain-wide structural connectivity alterations under the control of Alzheimer risk genes | 0.0 | 9 | Citations (PDF) |
| 189 | Multivariate genome wide association and network analysis of subcortical imaging phenotypes in Alzheimer’s disease | 3.2 | 15 | Citations (PDF) |
| 190 | Identifying Candidate Genetic Associations with MRI-Derived AD-Related ROI via Tree-Guided Sparse Learning | 3.0 | 13 | Citations (PDF) |
| 191 | MIND food and speed of processing training in older adults with low education, the MINDSpeed Alzheimer's disease prevention pilot trial | 1.6 | 12 | Citations (PDF) |
| 192 | Plasma amyloid beta levels are associated with cerebral amyloid and tau deposition | 2.4 | 89 | Citations (PDF) |
| 193 | Identifying progressive imaging genetic patterns via multi-task sparse canonical correlation analysis: a longitudinal study of the ADNI cohort | 4.7 | 56 | Citations (PDF) |
| 194 | Targeted genetic analysis of cerebral blood flow imaging phenotypes implicates the INPP5D gene | 3.4 | 40 | Citations (PDF) |
| 195 | Associations Between Depression, Traumatic Brain Injury, and Cognitively-Defined Late-Onset Alzheimer’s Disease Subgroups | 2.6 | 10 | Citations (PDF) |
| 196 | Telomere Shortening in the Alzheimer’s Disease Neuroimaging Initiative Cohort | 2.6 | 23 | Citations (PDF) |
| 197 | Association of Altered Liver Enzymes With Alzheimer Disease Diagnosis, Cognition, Neuroimaging Measures, and Cerebrospinal Fluid Biomarkers | 6.6 | 216 | Citations (PDF) |
| 198 | Genome-wide association analysis of hippocampal volume identifies enrichment of neurogenesis-related pathways | 3.4 | 30 | Citations (PDF) |
| 199 | Sleep disturbance and neurocognitive outcomes in older patients with breast cancer: Interaction with genotype | 4.0 | 41 | Citations (PDF) |
| 200 | Bile acids targeted metabolomics and medication classification data in the ADNI1 and ADNIGO/2 cohorts | 5.7 | 26 | Citations (PDF) |
| 201 | Prevalence of Potentially Clinically Significant Magnetic Resonance Imaging Findings in Athletes with and without Sport-Related Concussion | 3.6 | 53 | Citations (PDF) |
| 202 | Deep Learning in Alzheimer's Disease: Diagnostic Classification and Prognostic Prediction Using Neuroimaging Data | 3.9 | 663 | Citations (PDF) |
| 203 | Sets of coregulated serum lipids are associated with Alzheimer's disease pathophysiology | 2.4 | 61 | Citations (PDF) |
| 204 | White matter alterations in early‐stage Alzheimer's disease: A tract‐specific study | 2.4 | 82 | Citations (PDF) |
| 205 | Resting state network modularity along the prodromal late onset Alzheimer's disease continuum | 3.3 | 68 | Citations (PDF) |
| 206 | Neuropathological correlates and genetic architecture of microglial activation in elderly human brain | 13.7 | 166 | Citations (PDF) |
| 207 | The open diffusion data derivatives, brain data upcycling via integrated publishing of derivatives and reproducible open cloud services | 5.7 | 83 | Citations (PDF) |
| 208 | Intrinsic brain activity changes associated with adjuvant chemotherapy in older women with breast cancer: a pilot longitudinal study | 2.3 | 32 | Citations (PDF) |
| 209 | Exercise prevents obesity-induced cognitive decline and white matter damage in mice | 3.4 | 59 | Citations (PDF) |
| 210 | Biological Hallmarks of Cancer in Alzheimer’s Disease | 3.7 | 69 | Citations (PDF) |
| 211 | Progress in Polygenic Composite Scores in Alzheimer’s and Other Complex Diseases | 9.8 | 61 | Citations (PDF) |
| 212 | Identification of exon skipping events associated with Alzheimer’s disease in the human hippocampus | 1.7 | 23 | Citations (PDF) |
| 213 | Genetic meta-analysis of diagnosed Alzheimer’s disease identifies new risk loci and implicates Aβ, tau, immunity and lipid processing | 25.2 | 2,971 | Citations (PDF) |
| 214 | IC‐P‐137: STRUCTURAL CONNECTIVITY MAPPING IN THE HUMAN HIPPOCAMPAL SUBFIELDS USING SUPER‐RESOLUTION HYDI | 0.5 | 0 | Citations (PDF) |
| 215 | IC‐P‐032: IMPROVING PREDICTION OF COGNITIVE OUTCOMES FROM FUNCTIONAL CONNECTIVITY IN ALZHEIMER'S DISEASE | 0.5 | 2 | Citations (PDF) |
| 216 | IC‐P‐181: EARLY AND LATE‐ONSET ALZHEIMER'S DISEASE AND SUSPECTED NON‐ALZHEIMER PATHOPHYSIOLOGY WITHIN THE A/T/N FRAMEWORK | 0.5 | 0 | Citations (PDF) |
| 217 | IC‐P‐033: COVARYING PATTERNS OF FUNCTIONAL CONNECTIVITY WITH AMYLOID AND TAU DEPOSITION IN EARLY STAGE ALZHEIMER'S DISEASE | 0.5 | 0 | Citations (PDF) |
| 218 | IC‐P‐057: DYSREGULATED FC GAMMA R‐MEDIATED PHAGOCYTOSIS PATHWAY IN ALZHEIMER'S DISEASE: NETWORK‐BASED GENE EXPRESSION ANALYSIS | 0.5 | 0 | Citations (PDF) |
| 219 | IC‐P‐060: GLOBAL CORTICAL [F18]FLORTAUCIPIR ASSOCIATION WITH THE TOP 20 ALZHEIMER'S DISEASE RISK GENES | 0.5 | 0 | Citations (PDF) |
| 220 | IC‐P‐063: A TOPOGRAPHIC IMAGING BIOMARKER OF TDP43 PATHOLOGY IN AMNESTIC DEMENTIA BASED ON AUTOPSY‐DERIVED FDG‐PET PATTERNS | 0.5 | 3 | Citations (PDF) |
| 221 | IC‐P‐076: FDG‐PET REVEALS DISTINCT HYPOMETABOLIC TRAJECTORIES IN COGNITIVELY‐DEFINED SUBGROUPS OF ALZHEIMER'S DISEASE | 0.5 | 0 | Citations (PDF) |
| 222 | Epigenome-wide meta-analysis of blood DNA methylation and its association with subcortical volumes: findings from the ENIGMA Epigenetics Working Group | 7.8 | 56 | Citations (PDF) |
| 223 | Genetic architecture of subcortical brain structures in 38,851 individuals | 25.2 | 280 | Citations (PDF) |
| 224 | Pretreatment Psychoneurological Symptoms and Their Association With Longitudinal Cognitive Function and Quality of Life in Older Breast Cancer Survivors | 0.8 | 48 | Citations (PDF) |
| 225 | Understanding disease progression and improving Alzheimer's disease clinical trials: Recent highlights from the Alzheimer's Disease Neuroimaging Initiative | 0.5 | 461 | Citations (PDF) |
| 226 | Blood biomarkers for memory: toward early detection of risk for Alzheimer disease, pharmacogenomics, and repurposed drugs | 7.8 | 60 | Citations (PDF) |
| 227 | Network approaches to systems biology analysis of complex disease: integrative methods for multi-omics data | 6.6 | 230 | Citations (PDF) |
| 228 | The Impact of Using Different Reference Populations on Measurement of Breast Cancer-Related Cognitive Impairment Rates | 0.4 | 18 | Citations (PDF) |
| 229 | GPU Accelerated Browser for Neuroimaging Genomics | 2.6 | 1 | Citations (PDF) |
| 230 | A novel SCCA approach via truncated
ℓ
1-norm and truncated group lasso for brain imaging genetics | 4.7 | 40 | Citations (PDF) |
| 231 | Memory concerns in the early Alzheimer's disease prodrome: Regional association with tau deposition | 2.4 | 34 | Citations (PDF) |
| 232 | Topographic staging of tau positron emission tomography images | 2.4 | 47 | Citations (PDF) |
| 233 | Spatial patterns of neuroimaging biomarker change in individuals from families with autosomal dominant Alzheimer's disease: a longitudinal study | 17.9 | 558 | Citations (PDF) |
| 234 | International Cognition and Cancer Task Force Recommendations for Neuroimaging Methods in the Study of Cognitive Impairment in Non-CNS Cancer Patients | 4.6 | 104 | Citations (PDF) |
| 235 | Associations of the Top 20 Alzheimer Disease Risk Variants With Brain Amyloidosis | 17.6 | 122 | Citations (PDF) |
| 236 | Volumetric comparison of hippocampal subfields extracted from 4-minute accelerated vs. 8-minute high-resolution T2-weighted 3T MRI scans | 2.1 | 19 | Citations (PDF) |
| 237 | Acute White-Matter Abnormalities in Sports-Related Concussion: A Diffusion Tensor Imaging Study from the NCAA-DoD CARE Consortium | 3.6 | 85 | Citations (PDF) |
| 238 | Type 2 diabetes mellitus and cerebrospinal fluid Alzheimer's disease biomarker amyloid β1‐42 in Alzheimer's Disease Neuroimaging Initiative participants | 2.4 | 37 | Citations (PDF) |
| 239 | P3‐361: SCENE‐ENCODING ACTIVATION AND RESTING‐STATE FUNCTIONAL CONNECTIVITY IN OLDER ADULTS WITH SUBJECTIVE COGNITIVE DECLINE AND MILD COGNITIVE IMPAIRMENT | 0.5 | 0 | Citations (PDF) |
| 240 | IC‐P‐086: COMPARISON BETWEEN THREE VOLUMETRIC MRI Z‐SCORE NORMING METHODS ACROSS THE ALZHEIMER DISEASE SPECTRUM | 0.5 | 0 | Citations (PDF) |
| 241 | P2‐459: THE COGNITIVE CHANGE INDEX IS ASSOCIATED WITH TAU DEPOSITION ON [18F]FLORTAUCIPIR | 0.5 | 0 | Citations (PDF) |
| 242 | IC‐P‐105: LONGITUDINAL PATTERNS OF DECLINE IN SUBTYPES OF AMNESTIC EARLY ONSET AD | 0.5 | 0 | Citations (PDF) |
| 243 | P2‐509: HEART FAILURE PREDICTS COGNITIVE DYSFUNCTION AFTER ADJUSTING FOR APOE FACTORS | 0.5 | 0 | Citations (PDF) |
| 244 | P4‐099: MULTIVARIATE CLUSTER PROFILING OF AMYLOID BETA, TAU, NEURODEGENERATION AND VASCULAR (ATNV) BIOMARKERS IN THE ADNI COHORT: IMPLICATIONS FOR COGNITION, –OMICS AND CLINICAL TRIALS | 0.5 | 0 | Citations (PDF) |
| 245 | P3‐120: DNA METHYLATION DYNAMICS IN ALZHEIMER'S DISEASE: DEVELOPMENT OF BIOMARKERS AND NOVEL DRUG TARGETS USING ADNI EPIGENETIC DATA | 0.5 | 0 | Citations (PDF) |
| 246 | IC‐P‐108: COMBINATORIAL SENSORY MODALITY ASSESSMENT IN PRODROMAL ALZHEIMER'S DISEASE: RELATION TO MRI AND AMYLOID AND TAU PET | 0.5 | 0 | Citations (PDF) |
| 247 | P2‐253: EP300 IS ASSOCIATED WITH ALTERED BILE ACIDS IN ALZHEIMER'S DISEASE | 0.5 | 0 | Citations (PDF) |
| 248 | P4‐031: NOVEL MODELS OF LATE‐ONSET ALZHEIMER'S DISEASE BASED ON GWAS | 0.5 | 1 | Citations (PDF) |
| 249 | IC‐P‐109: THE COGNITIVE CHANGE INDEX IS ASSOCIATED WITH TAU DEPOSITION ON [18F]FLORTAUCIPIR | 0.5 | 0 | Citations (PDF) |
| 250 | IC‐P‐092: COGNITIVELY DEFINED SUBTYPES OF ALZHEIMER'S DISEASE ARE ASSOCIATED WITH DISTINCT PATTERNS OF ATROPHY | 0.5 | 1 | Citations (PDF) |
| 251 | P3‐396: WHITE‐MATTER MICROSTRUCTURE IN EARLY STAGE ALZHEIMER'S DISEASE | 0.5 | 0 | Citations (PDF) |
| 252 | P4‐105: A SIMPLE METHOD FOR DEFINING ATROPHY SUBTYPES IN INDIVIDUAL SUBJECTS ACROSS THE ALZHEIMER'S DISEASE SPECTRUM | 0.5 | 0 | Citations (PDF) |
| 253 | IC‐P‐085: A SIMPLE METHOD FOR DEFINING ATROPHY SUBTYPES IN INDIVIDUAL SUBJECTS ACROSS THE ALZHEIMER DISEASE SPECTRUM | 0.5 | 0 | Citations (PDF) |
| 254 | P3‐618: HIGH RED MEAT INTAKE IS ASSOCIATED WITH INCREASED TAU ON [18F]FLORTAUCIPIR PET AND POORER MEMORY | 0.5 | 0 | Citations (PDF) |
| 255 | P2‐435: SEPARATION OF FUNCTIONAL CONNECTOMES ACROSS THE AD SPECTRUM BASED ON DISEASE SENSITIVE PRINCIPAL COMPONENTS | 0.5 | 0 | Citations (PDF) |
| 256 | IC‐P‐219: [18F]‐AV‐1451 BINDING PROFILE IN EARLY AND LATE‐ONSET ALZHEIMER'S DISEASE AND SUSPECTED NON‐ALZHEIMER PATHOPHYSIOLOGY | 0.5 | 0 | Citations (PDF) |
| 257 | O2‐03‐03: COGNITIVELY DEFINED SUBTYPES OF ALZHEIMER'S DISEASE ARE ASSOCIATED WITH DISTINCT PATTERNS OF ATROPHY | 0.5 | 0 | Citations (PDF) |
| 258 | IC‐P‐214: HIGH RED MEAT INTAKE IS ASSOCIATED WITH INCREASED TAU ON [18F]FLORTAUCIPIR PET AND POORER MEMORY | 0.5 | 0 | Citations (PDF) |
| 259 | IC‐P‐178: COMPARING HIPPOCAMPAL EFFECT SIZE BETWEEN ALZHEIMER'S DISEASE AND HEALTHY CONTROLS USING OLDER AND NEWER VERSIONS OF SPM AND FREESURFER | 0.5 | 0 | Citations (PDF) |
| 260 | IC‐P‐172: WHITE‐MATTER MICROSTRUCTURE IN EARLY STAGE ALZHEIMER'S DISEASE | 0.5 | 0 | Citations (PDF) |
| 261 | F3‐02‐01: ALTERED BILE ACID METABOLITES IN MILD COGNITIVE IMPAIRMENT AND ALZHEIMER'S DISEASE: RELATION TO NEUROIMAGING AND CSF BIOMARKERS | 0.5 | 0 | Citations (PDF) |
| 262 | IC‐P‐044: SEPARATION OF FUNCTIONAL CONNECTOMES ACROSS THE AD SPECTRUM BASED ON DISEASE‐SENSITIVE PRINCIPAL COMPONENTS | 0.5 | 0 | Citations (PDF) |
| 263 | IC‐P‐075: GENETIC FINDINGS USING ADNI MULTIMODAL QUANTITATIVE PHENOTYPES: A 2017 UPDATE | 0.5 | 0 | Citations (PDF) |
| 264 | IC‐P‐157: ALTERATIONS IN WHITE‐MATTER DIFFUSION METRICS IN PRECLINICAL ALZHEIMER'S DISEASE: A SUBJECT‐SPECIFIC ANALYSIS | 0.5 | 0 | Citations (PDF) |
| 265 | O3‐13‐04: [18F]‐AV‐1451 BINDING PROFILE IN EARLY AND LATE‐ONSET ALZHEIMER'S DISEASE AND SUSPECTED NON‐ALZHEIMER PATHOPHYSIOLOGY | 0.5 | 0 | Citations (PDF) |
| 266 | P3‐105: GENETIC VARIATION OF ANTI‐AGING GENE FGF23 IS ASSOCIATED WITH LARGER CORTICAL THICKNESS IN ALZHEIMER'S DISEASE | 0.5 | 0 | Citations (PDF) |
| 267 | P4‐091: ALZHEIMER'S DISEASE TAU PET SUBTYPES IN THE ADNI SAMPLE | 0.5 | 0 | Citations (PDF) |
| 268 | P3‐377: COMPARING HIPPOCAMPAL EFFECT SIZE BETWEEN ALZHEIMER'S DISEASE AND HEALTHY CONTROLS USING OLDER AND NEWER VERSIONS OF SPM AND FREESURFER | 0.5 | 0 | Citations (PDF) |
| 269 | P3‐483: COGNITIVELY DEFINED LOAD SUBGROUPS ARE CHARACTERIZED BY HETEROGENEOUS PATTERNS OF RELATIVE DEFICITS IN THE FIVE YEARS PRECEDING LOAD DIAGNOSIS | 0.5 | 0 | Citations (PDF) |
| 270 | P2‐235: GENETIC FINDINGS USING ADNI MULTIMODAL QUANTITATIVE PHENOTYPES: A 2018 UPDATE | 0.5 | 0 | Citations (PDF) |
| 271 | IC‐P‐072: GENETIC VARIATION OF ANTI‐AGING GENE FGF23 IS ASSOCIATED WITH LARGER CORTICAL THICKNESS IN ALZHEIMER'S DISEASE | 0.5 | 0 | Citations (PDF) |
| 272 | Utility of perfusion PET measures to assess neuronal injury in Alzheimer's disease | 2.4 | 19 | Citations (PDF) |
| 273 | P2‐103: GENOME‐WIDE ASSOCIATION OF TOP ALZHEIMER'S DISEASE ENDOPHENOTYPES IN ADNI DATASET | 0.5 | 0 | Citations (PDF) |
| 274 | P3‐371: ALTERATIONS IN WHITE‐MATTER DIFFUSION METRICS IN PRECLINICAL ALZHEIMER'S DISEASE: A SUBJECT‐SPECIFIC ANALYSIS | 0.5 | 0 | Citations (PDF) |
| 275 | IC‐P‐070: GENOME‐WIDE ASSOCIATION OF TOP ALZHEIMER'S DISEASE ENDOPHENOTYPES IN ADNI DATASET | 0.5 | 0 | Citations (PDF) |
| 276 | P3‐336: SUBJECTIVE COGNITIVE DECLINE (SCD) AND MILD BEHAVIORAL IMPAIRMENT (MBI): THE INTERSECTION OF TWO EARLY INDICATORS OF AD PATHOPHYSIOLOGY | 0.5 | 0 | Citations (PDF) |
| 277 | Detection of tau in Gerstmann-Sträussler-Scheinker disease (PRNP F198S) by [18F]Flortaucipir PET | 5.0 | 16 | Citations (PDF) |
| 278 | P3‐351: COGNITIVE COMPLAINTS IN POSTMENOPAUSAL WOMEN ARE ASSOCIATED WITH REDUCED HIPPOCAMPAL GRAY MATTER VOLUME | 0.5 | 0 | Citations (PDF) |
| 279 | Rare variants in the splicing regulatory elements of EXOC3L4 are associated with brain glucose metabolism in Alzheimer’s disease | 1.7 | 13 | Citations (PDF) |
| 280 | Quantitative trait loci identification for brain endophenotypes via new additive model with random networks | 4.7 | 12 | Citations (PDF) |
| 281 | Subcortical brain iron deposition and cognitive performance in older women with breast cancer receiving adjuvant chemotherapy: A pilot MRI study | 1.8 | 14 | Citations (PDF) |
| 282 | Analysis of shared heritability in common disorders of the brain | 36.2 | 1,407 | Citations (PDF) |
| 283 | Exome Chip Analysis Identifies Low-Frequency and Rare Variants in
MRPL38
for White Matter Hyperintensities on Brain Magnetic Resonance Imaging | 5.9 | 24 | Citations (PDF) |
| 284 | Longitudinal Genotype–Phenotype Association Study through Temporal Structure Auto-Learning Predictive Model | 1.5 | 8 | Citations (PDF) |
| 285 | A Longitudinal Imaging Genetics Study of Neuroanatomical Asymmetry in Alzheimer’s Disease | 5.4 | 53 | Citations (PDF) |
| 286 | Assessing brain volume changes in older women with breast cancer receiving adjuvant chemotherapy: a brain magnetic resonance imaging pilot study | 4.7 | 41 | Citations (PDF) |
| 287 | Sex Differences in Cognitive Decline in Subjects with High Likelihood of Mild Cognitive Impairment due to Alzheimer’s disease | 3.4 | 143 | Citations (PDF) |
| 288 | Task‐evoked functional connectivity does not explain functional connectivity differences between rest and task conditions | 3.5 | 58 | Citations (PDF) |
| 289 | Gray matter density reduction associated with adjuvant chemotherapy in older women with breast cancer | 2.3 | 41 | Citations (PDF) |
| 290 | White matter hyperintensities and the mediating role of cerebral amyloid angiopathy in dominantly-inherited Alzheimer’s disease | 2.3 | 70 | Citations (PDF) |
| 291 | Cerebral blood flow in acute concussion: preliminary ASL findings from the NCAA-DoD CARE consortium | 2.1 | 63 | Citations (PDF) |
| 292 | Genetic data and cognitively defined late-onset Alzheimer’s disease subgroups | 7.8 | 84 | Citations (PDF) |
| 293 | Genome-wide association study of brain amyloid deposition as measured by Pittsburgh Compound-B (PiB)-PET imaging | 7.8 | 71 | Citations (PDF) |
| 294 | Brain and blood metabolite signatures of pathology and progression in Alzheimer disease: A targeted metabolomics study | 8.0 | 473 | Citations (PDF) |
| 295 | Adult neurogenesis and neurodegenerative diseases: A systems biology perspective | 1.5 | 160 | Citations (PDF) |
| 296 | Novel genetic loci associated with hippocampal volume | 13.7 | 298 | Citations (PDF) |
| 297 | Cognitive complaints in older adults at risk for Alzheimer's disease are associated with altered resting‐state networks | 2.4 | 54 | Citations (PDF) |
| 298 | Genome-wide association study identifies four novel loci associated with Alzheimer’s endophenotypes and disease modifiers | 9.1 | 246 | Citations (PDF) |
| 299 | Single‐nucleotide polymorphisms are associated with cognitive decline at Alzheimer's disease conversion within mild cognitive impairment patients | 2.4 | 41 | Citations (PDF) |
| 300 | Plasma Tau Association with Brain Atrophy in Mild Cognitive Impairment and Alzheimer’s Disease | 2.6 | 65 | Citations (PDF) |
| 301 | Tissue-specific network-based genome wide study of amygdala imaging phenotypes to identify functional interaction modules | 4.7 | 25 | Citations (PDF) |
| 302 | Recent publications from the Alzheimer's Disease Neuroimaging Initiative: Reviewing progress toward improved AD clinical trials | 0.5 | 270 | Citations (PDF) |
| 303 | Age at injury is associated with the long‐term cognitive outcome of traumatic brain injuries | 2.4 | 19 | Citations (PDF) |
| 304 | Mining Outcome-relevant Brain Imaging Genetic Associations via Three-way Sparse Canonical Correlation Analysis in Alzheimer’s Disease | 3.4 | 52 | Citations (PDF) |
| 305 | Exploring the nexus of Alzheimer's disease and related dementias with cancer and cancer therapies: A convening of the Alzheimer's Association & Alzheimer's Drug Discovery Foundation | 0.5 | 39 | Citations (PDF) |
| 306 | The Alzheimer's Disease Neuroimaging Initiative 3: Continued innovation for clinical trial improvement | 0.5 | 473 | Citations (PDF) |
| 307 | Alzheimer disease brain atrophy subtypes are associated with cognition and rate of decline | 1.0 | 160 | Citations (PDF) |
| 308 | Targeted neurogenesis pathway-based gene analysis identifies ADORA2A associated with hippocampal volume in mild cognitive impairment and Alzheimer's disease | 3.4 | 83 | Citations (PDF) |
| 309 | Olfactory identification in subjective cognitive decline and mild cognitive impairment: Association with tau but not amyloid positron emission tomography | 2.4 | 59 | Citations (PDF) |
| 310 | [P3–087]: MICRORNA AND GENE NETWORKS UNDERLYING THE INVERSE ASSOCIATION OF CANCER AND ALZHEIMER's DISEASE | 0.5 | 0 | Citations (PDF) |
| 311 | Targeted metabolomics and medication classification data from participants in the ADNI1 cohort | 5.7 | 74 | Citations (PDF) |
| 312 | Brain explorer for connectomic analysis | 3.7 | 4 | Citations (PDF) |
| 313 | Rare coding variants in PLCG2, ABI3, and TREM2 implicate microglial-mediated innate immunity in Alzheimer's disease | 25.2 | 1,010 | Citations (PDF) |
| 314 | [IC‐P‐084]: VISUAL LEARNING ON THE COGSTATE BATTERY IS ASSOCIATED WITH AMYLOID, TAU, AND NEURODEGENERATION IN COGNITIVELY NORMAL OLDER ADULTS | 0.5 | 0 | Citations (PDF) |
| 315 | [P4–420]: DEVELOPMENT OF A TAU BIOLOGICAL NETWORK FOR GENETIC ANALYSIS OF TAUOPATHIES | 0.5 | 0 | Citations (PDF) |
| 316 | [IC‐01–04]: A ROBUST, SIMPLIFIED BRAAK‐TYPE CLASSIFICATION SCHEME FOR FLORTAUCIPIR F‐18 TAU PET IMAGES | 0.5 | 0 | Citations (PDF) |
| 317 | Genome-wide association and interaction studies of CSF T-tau/Aβ42 ratio in ADNI cohort | 3.4 | 39 | Citations (PDF) |
| 318 | Association analysis of rare variants near the APOE region with CSF and neuroimaging biomarkers of Alzheimer’s disease | 1.7 | 34 | Citations (PDF) |
| 319 | Genome-wide network-based pathway analysis of CSF t-tau/Aβ1-42 ratio in the ADNI cohort | 3.2 | 18 | Citations (PDF) |
| 320 | Knowledge-driven binning approach for rare variant association analysis: application to neuroimaging biomarkers in Alzheimer’s disease | 3.1 | 19 | Citations (PDF) |
| 321 | Two-dimensional enrichment analysis for mining high-level imaging genetic associations | 3.7 | 14 | Citations (PDF) |
| 322 | Pattern Discovery in Brain Imaging Genetics via SCCA Modeling with a Generic Non-convex Penalty | 3.4 | 11 | Citations (PDF) |
| 323 | [P2–372]: UTILITY OF PERFUSION PET MODELS AS MEASURES OF NEURODEGENERATION IN AN AUTOSOMAL DOMINANT ALZHEIMER's DISEASE POPULATION: REPORT FROM THE DIAN STUDY | 0.5 | 0 | Citations (PDF) |
| 324 | [IC‐P‐056]: ADORA2A POLYMORPHISM IS ASSOCIATED WITH CEREBRAL BLOOD FLOW IN MILD COGNITIVE IMPAIRMENT (MCI) AND ALZHEIMER'S DISEASE | 0.5 | 0 | Citations (PDF) |
| 325 | [P1–245]: HETEROGENEITY OF RISK ACROSS NON‐VASCULAR RISK FACTORS FOR SPECIFIC COGNITIVELY‐DEFINED ALZHEIMER's DISEASE SUBGROUPS | 0.5 | 0 | Citations (PDF) |
| 326 | [P2–356]: COMPARING IMAGING PHENOTYPES OF AMNESTIC EARLY VERSUS LATE‐ONSET AMYLOID‐POSITIVE MILD COGNITIVE IMPAIRMENT AND DEMENTIA ADNI SUBJECTS | 0.5 | 0 | Citations (PDF) |
| 327 | [P2–364]: VISUAL LEARNING ON THE COGSTATE BATTERY IS ASSOCIATED WITH AMYLOID, TAU, AND NEURODEGENERATION IN COGNITIVELY NORMAL OLDER ADULTS | 0.5 | 0 | Citations (PDF) |
| 328 | [P2–417]: LANGUAGE FLUENCY PREDICTS RESTING STATE NETWORK CONNECTIVITY PATTERN | 0.5 | 0 | Citations (PDF) |
| 329 | [P3–088]: KLK8 AS A MODULATOR OF ALZHEIMER's DISEASE PATHOLOGY: NEUROIMAGING GENETICS | 0.5 | 2 | Citations (PDF) |
| 330 | [P3–311]: A ROBUST, SIMPLIFIED BRAAK‐TYPE CLASSIFICATION SCHEME FOR FLORTAUCIPIR F 18 TAU PET IMAGES | 0.5 | 0 | Citations (PDF) |
| 331 | [P4–030]: ROLE OF SP1 AND OTHER TRANSCRIPTION FACTORS (TFS) IN ALZHEIMER's DISEASE (AD) | 0.5 | 0 | Citations (PDF) |
| 332 | [P4–190]: SELECTIVE ESTROGEN EFFECTS ON CHOLINERGIC‐RELATED COGNITIVE PERFORMANCE AND FMRI IN POSTMENOPAUSAL WOMEN WITH AND WITHOUT SUBJECTIVE COGNITIVE DECLINE | 0.5 | 1 | Citations (PDF) |
| 333 | [P1–142]: DNA METHYLATION DYNAMICS IN ALZHEIMER's DISEASE DIAGNOSIS AND PROGRESSION | 0.5 | 3 | Citations (PDF) |
| 334 | [P4–224]: AXONAL DENSITY IS ASSOCIATED WITH SUBJECTIVE COGNITIVE DECLINE (SCD) IN OLDER ADULTS ASSESSED USING THE COGNITIVE CHANGE INDEX | 0.5 | 1 | Citations (PDF) |
| 335 | [P1–151]: VEGFA IS ASSOCIATED WITH CEREBRAL BLOOD FLOW AND WHITE MATTER HYPERINTENSITY IN MILD COGNITIVE IMPAIRMENT (MCI) AND ALZHEIMER'S DISEASE | 0.5 | 0 | Citations (PDF) |
| 336 | [P4–386]: COMPARING IMAGING PHENOTYPES OF AMNESTIC EARLY‐ VERSUS LATE‐ONSET AMYLOID‐NEGATIVE MILD COGNITIVE IMPAIRMENT AND DEMENTIA ADNI SUBJECTS | 0.5 | 0 | Citations (PDF) |
| 337 | [IC‐P‐027]: LANGUAGE FLUENCY PREDICTS RESTING STATE NETWORK CONNECTIVITY PATTERN | 0.5 | 0 | Citations (PDF) |
| 338 | [IC‐P‐063]: KLK8 AS A MODULATOR OF ALZHEIMER's DISEASE PATHOLOGY: NEUROIMAGING GENETICS | 0.5 | 1 | Citations (PDF) |
| 339 | [IC‐P‐070]: ASSOCIATIONS BETWEEN SOCIAL NETWORK CHARACTERISTICS AND CORTICAL THICKNESS AND HIPPOCAMPAL VOLUME IN COGNITIVELY NORMAL SUBJECTS | 0.5 | 1 | Citations (PDF) |
| 340 | [IC‐P‐099]: NEURODEGENERATIVE PATTERNS OF COGNITIVE CLUSTERS OF EARLY ONSET AD SUBJECTS: EVIDENCE FOR DISEASE HETEROGENEITY | 0.5 | 0 | Citations (PDF) |
| 341 | [IC‐P‐105]: COMPARING IMAGING PHENOTYPES OF AMNESTIC EARLY‐ VERSUS LATE‐ONSET AMYLOID‐POSITIVE MILD COGNITIVE IMPAIRMENT AND DEMENTIA ADNI SUBJECTS | 0.5 | 0 | Citations (PDF) |
| 342 | [IC‐P‐166]: UTILITY OF PERFUSION PET MODELS AS MEASURE OF NEURODEGENERATION IN AN AUTOSOMAL DOMINANT ALZHEIMER's DISEASE POPULATION: REPORT FROM THE DIAN STUDY | 0.5 | 0 | Citations (PDF) |
| 343 | [IC‐P‐216]: COMPARING IMAGING PHENOTYPES OF AMNESTIC EARLY VERSUS LATE‐ONSET AMYLOID‐NEGATIVE MILD COGNITIVE IMPAIRMENT AND DEMENTIA ADNI SUBJECTS | 0.5 | 0 | Citations (PDF) |
| 344 | [IC‐02–04]: AXONAL DENSITY IS ASSOCIATED WITH SUBJECTIVE COGNITIVE DECLINE (SCD) IN OLDER ADULTS ASSESSED USING THE COGNITIVE CHANGE INDEX | 0.5 | 0 | Citations (PDF) |
| 345 | [P1–449]: RESTING STATE NETWORK MODULARITY ALONG THE PRODROMAL LATE ONSET ALZHEIMER's DISEASE CONTINUUM | 0.5 | 1 | Citations (PDF) |
| 346 | [P1–552]: SOCIAL NETWORKS AND COGNITIVE PERFORMANCE IN OLDER ADULTS WITH NORMAL COGNITION, MILD COGNITIVE IMPAIRMENT, AND MILD ALZHEIMER's DISEASE | 0.5 | 1 | Citations (PDF) |
| 347 | [P2–111]: ADORA2A POLYMORPHISM IS ASSOCIATED WITH CEREBRAL BLOOD FLOW IN MILD COGNITIVE IMPAIRMENT (MCI) AND ALZHEIMER'S DISEASE | 0.5 | 0 | Citations (PDF) |
| 348 | [P2–120]: INVESTIGATION OF GENETIC INFLUENCES ON ATROPHY RATE DURING THE MCI DISEASE STAGE USING A BOOTSTRAP‐ENHANCED SPARSE ASSOCIATION MODEL | 0.5 | 0 | Citations (PDF) |
| 349 | [P2–220]: GENETIC FINDINGS USING ADNI MULTIMODAL QUANTITATIVE PHENOTYPES: A 2016 UPDATE | 0.5 | 0 | Citations (PDF) |
| 350 | [F1–02–04]: INTEGRATING MULTI‐MODALITY IMAGING AND MULTI‐LAYER ‐OMICS TO ADVANCE THE SYSTEMS BIOLOGY OF ALZHEIMER's DISEASE | 0.5 | 0 | Citations (PDF) |
| 351 | [O1–11–02]: GENOME‐WIDE ASSOCIATION ANALYSIS OF TAU ACCUMULATION IDENTIFIES ENRICHMENT OF NEUROGENESIS‐RELATED PATHWAYS | 0.5 | 0 | Citations (PDF) |
| 352 | [O1–11–03]: CEREBROSPINAL FLUID ENDOPHENOTYPES PROVIDE INSIGHT INTO BIOLOGY UNDERLYING ALZHEIMER'S DISEASE | 0.5 | 0 | Citations (PDF) |
| 353 | [O3–03–02]: NEURODEGENERATIVE PATTERNS OF COGNITIVE CLUSTERS OF EARLY ONSET AD SUBJECTS: EVIDENCE FOR DISEASE HETEROGENEITY | 0.5 | 0 | Citations (PDF) |
| 354 | [P4–421]: ELEVATED PLASMA NEUROFILAMENT LIGHT CHAIN IS ASSOCIATED WITH REDUCED GREY MATTER DENSITY IN AD AND MCI | 0.5 | 0 | Citations (PDF) |
| 355 | [P4–534]: LINKING MEASURES OF SUBJECTIVE COGNITION ACROSS INTERNATIONAL AGING STUDIES USING ITEM RESPONSE THEORY | 0.5 | 1 | Citations (PDF) |
| 356 | [P1–461]: CSF Aβ1–42 AS THE PATHOLOGICAL AD BIOMARKER IN TYPE 2 DIABETES MELLITUS PATIENTS | 0.5 | 0 | Citations (PDF) |
| 357 | [P1–582]: DIFFERENTIAL VASCULAR RISK FACTORS FOR COGNITIVELY DEFINED ALZHEIMER's DISEASE SUBGROUPS | 0.5 | 0 | Citations (PDF) |
| 358 | [P3–530]: ASSOCIATIONS BETWEEN SOCIAL NETWORK CHARACTERISTICS AND CORTICAL THICKNESS AND HIPPOCAMPAL VOLUME IN COGNITIVELY NORMAL SUBJECTS | 0.5 | 0 | Citations (PDF) |
| 359 | Identification of associations between genotypes and longitudinal phenotypes via temporally-constrained group sparse canonical correlation analysis | 4.7 | 55 | Citations (PDF) |
| 360 | Characterizing Gene and Protein Crosstalks in Subjects at Risk of Developing Alzheimer’s Disease: A New Computational Approach | 2.5 | 2 | Citations (PDF) |
| 361 | Mapping longitudinal scientific progress, collaboration and impact of the Alzheimer’s disease neuroimaging initiative | 2.3 | 11 | Citations (PDF) |
| 362 | Stability of MRI metrics in the advanced research core of the NCAA-DoD concussion assessment, research and education (CARE) consortium | 2.1 | 28 | Citations (PDF) |
| 363 | Genome-wide association study of language performance in Alzheimer’s disease | 1.8 | 22 | Citations (PDF) |
| 364 | Genetic Influences on Plasma Homocysteine Levels in African Americans and Yoruba Nigerians | 2.6 | 16 | Citations (PDF) |
| 365 | Altered Brain Connectivity in Early Postmenopausal Women with Subjective Cognitive Impairment | 2.7 | 43 | Citations (PDF) |
| 366 | Quantitative Amyloid Imaging in Autosomal Dominant Alzheimer’s Disease: Results from the DIAN Study Group | 2.3 | 53 | Citations (PDF) |
| 367 | Reply | 6.6 | 0 | Citations (PDF) |
| 368 | The effect of the top 20 Alzheimer disease risk genes on gray‐matter density and FDG PET brain metabolism | 2.4 | 43 | Citations (PDF) |
| 369 | IC‐P‐059: Examining The Effect of The Top 20 Ad Risk Variants on Brain Amyloidosis, Structural Atrophy and Metabolism | 0.5 | 0 | Citations (PDF) |
| 370 | IC‐P‐061: Alzheimer’s Disease Risk Genes Can Predict Brain Amyloidosis | 0.5 | 0 | Citations (PDF) |
| 371 | IC‐P‐072: Gene Expression Of ABCA7 Dysregulated in Peripheral Blood is Associated With Decreased Metabolic Activity in Hippocampus | 0.5 | 0 | Citations (PDF) |
| 372 | IC‐P‐074: Genome‐Wide Meta‐Analysis of Transcriptome Profiling Identifies Novel Dysregulated Genes Implicated in Alzheimer’s Disease | 0.5 | 0 | Citations (PDF) |
| 373 | P2‐074: A Meta‐Analysis Identifies ADORA2A Associated with Hippocampal Volume in Alzheimer’s Disease | 0.5 | 1 | Citations (PDF) |
| 374 | P2‐098: Whole Brain Surface‐Based Analysis Identified Brain Atrophy Associated with SNPS in FRMD6 Linked to Alzheimer's Disease | 0.5 | 2 | Citations (PDF) |
| 375 | IC‐P‐109: Plasma TAU Levels in Mild Cognitive Impairment and Alzheimer’s Disease | 0.5 | 0 | Citations (PDF) |
| 376 | P2‐233: Alzheimer's Disease Risk Genes Can Predict Brain Amyloidosis | 0.5 | 0 | Citations (PDF) |
| 377 | P3‐087: Gene Expression of ABCA7 Dysregulated in Peripheral Blood is Associated With Decreased Metabolic Activity in Hippocampus | 0.5 | 0 | Citations (PDF) |
| 378 | O2‐06‐02: Genome‐Wide Meta‐Analysis of Transcriptome Profiling Identifies Novel Dysregulated Genes Implicated in Alzheimer's Disease | 0.5 | 0 | Citations (PDF) |
| 379 | O2‐10‐01: Genome‐Wide Association Analysis of Hippocampal Volume Identifies Enrichment of Neurogenesis‐Related Pathways | 0.5 | 0 | Citations (PDF) |
| 380 | O5‐01‐04: EXAMINING THE EFFECT OF THE TOP 20 ALZHEIMER'S DISEASE RISK VARIANTS ON BRAIN AMYLOIDOSIS, STRUCTURAL ATROPHY AND METABOLISM | 0.5 | 1 | Citations (PDF) |
| 381 | P1‐117: Blood Gene Expression Changes Implicated in Alzheimer’s Disease | 0.5 | 0 | Citations (PDF) |
| 382 | P4‐344: Volumetric Comparison of Automatically Segmented Hippocampal Subfields From 4‐Min Accelerated Versus 8‐Min T2‐Weighted 3T Mri Scans | 0.5 | 0 | Citations (PDF) |
| 383 | The Cognitive Change Index as a Measure of Self and Informant Perception of Cognitive Decline: Relation to Neuropsychological Tests | 2.6 | 143 | Citations (PDF) |
| 384 | Mood, stress and longevity: convergence on ANK3 | 7.8 | 26 | Citations (PDF) |
| 385 | Assessment of the genetic variance of late-onset Alzheimer's disease | 3.4 | 216 | Citations (PDF) |
| 386 | Association Between Anticholinergic Medication Use and Cognition, Brain Metabolism, and Brain Atrophy in Cognitively Normal Older Adults | 17.6 | 322 | Citations (PDF) |
| 387 | Externalizing personality traits, empathy, and gray matter volume in healthy young drinkers | 1.9 | 14 | Citations (PDF) |
| 388 | Identifying significant gene‐environment interactions using a combination of screening testing and hierarchical false discovery rate control | 3.1 | 20 | Citations (PDF) |
| 389 | Novel genetic loci underlying human intracranial volume identified through genome-wide association | 17.1 | 241 | Citations (PDF) |
| 390 | Alpha-synuclein (SNCA) polymorphisms exert protective effects on memory after mild traumatic brain injury | 1.9 | 5 | Citations (PDF) |
| 391 | Evaluating the impact of chemotherapy-induced peripheral neuropathy symptoms (CIPN-sx) on perceived ability to work in breast cancer survivors during the first year post-treatment | 2.2 | 63 | Citations (PDF) |
| 392 | Reliable change in neuropsychological assessment of breast cancer survivors | 3.0 | 38 | Citations (PDF) |
| 393 | Type 2 diabetes mellitus is associated with brain atrophy and hypometabolism in the ADNI cohort | 1.0 | 109 | Citations (PDF) |
| 394 | Integration of bioinformatics and imaging informatics for identifying rare PSEN1 variants in Alzheimer’s disease | 1.7 | 23 | Citations (PDF) |
| 395 | Genomics and CSF analyses implicate thyroid hormone in hippocampal sclerosis of aging | 9.1 | 30 | Citations (PDF) |
| 396 | Hippocampal Sclerosis of Aging, a Common Alzheimer’s Disease ‘Mimic’: Risk Genotypes are Associated with Brain Atrophy Outside the Temporal Lobe | 2.6 | 30 | Citations (PDF) |
| 397 | Structured sparse CCA for brain imaging genetics via graph OSCAR | 3.1 | 11 | Citations (PDF) |
| 398 | Identifying Multimodal Intermediate Phenotypes Between Genetic Risk Factors and Disease Status in Alzheimer’s Disease | 2.6 | 34 | Citations (PDF) |
| 399 | White matter hyperintensities are a core feature of Alzheimer's disease: Evidence from the dominantly inherited Alzheimer network | 6.6 | 528 | Citations (PDF) |
| 400 | Traumatic brain injury and age at onset of cognitive impairment in older adults | 3.4 | 73 | Citations (PDF) |
| 401 | The executive prominent/memory prominent spectrum in Alzheimer's disease is highly heritable | 3.4 | 12 | Citations (PDF) |
| 402 | Apathy Is Associated With Ventral Striatum Volume in Schizophrenia Spectrum Disorder | 2.3 | 20 | Citations (PDF) |
| 403 | Structured sparse canonical correlation analysis for brain imaging genetics: an improved GraphNet method | 4.7 | 115 | Citations (PDF) |
| 404 | Genetic influences on schizophrenia and subcortical brain volumes: large-scale proof of concept | 17.1 | 229 | Citations (PDF) |
| 405 | Methylphenidate and Memory and Attention Adaptation Training for Persistent Cognitive Symptoms after Traumatic Brain Injury: A Randomized, Placebo-Controlled Trial | 5.4 | 71 | Citations (PDF) |
| 406 | P4‐191: Gwas identifies gli3 as a novel gene for language deficits and cortical changes in older adults at‐risk for Alzheimer's disease | 0.5 | 0 | Citations (PDF) |
| 407 | Alzheimer risk genes modulate the relationship between plasma apoE and cortical PiB binding | 2.8 | 15 | Citations (PDF) |
| 408 | Subjective Cognitive Decline in Older Adults: An Overview of Self-Report Measures Used Across 19 International Research Studies | 2.6 | 413 | Citations (PDF) |
| 409 | P4‐197: Gene expression profiling identifies altered networks in late‐onset Alzheimer's disease: Immune response and mitochondrial process | 0.5 | 0 | Citations (PDF) |
| 410 | O4‐05‐01: Gwas of longitudinal amyloid PET identifies IL1RAP as a new potential Alzheimer's disease target | 0.5 | 0 | Citations (PDF) |
| 411 | The role of visualization and 3-D printing in biological data mining | 3.6 | 5 | Citations (PDF) |
| 412 | Relationship between the Montreal Cognitive Assessment and Mini-mental State Examination for assessment of mild cognitive impairment in older adults | 3.2 | 558 | Citations (PDF) |
| 413 | Reply | 6.6 | 2 | Citations (PDF) |
| 414 | Reply | 6.6 | 2 | Citations (PDF) |
| 415 | Reply | 6.6 | 0 | Citations (PDF) |
| 416 | Increased brain activation during working memory processing after pediatric mild traumatic brain injury (mTBI) | 0.4 | 47 | Citations (PDF) |
| 417 | Comprehensive Gene- and Pathway-Based Analysis of Depressive Symptoms in Older Adults | 2.6 | 38 | Citations (PDF) |
| 418 | Rarity of the Alzheimer Disease–ProtectiveAPPA673T Variant in the United States | 17.6 | 48 | Citations (PDF) |
| 419 | The Structural and Functional Connectome and Prediction of Risk for Cognitive Impairment in Older Adults | 1.0 | 51 | Citations (PDF) |
| 420 | O1‐04‐04: Effect of hypertension and antihypertensive medication on executive function, brain atrophy, and white matter hyperintensities | 0.5 | 0 | Citations (PDF) |
| 421 | O4‐10‐04: Extension of a validation study of the cognitive change index (CCI) tool to measure self and informant perception of cognitive decline: Relation to test performance | 0.5 | 0 | Citations (PDF) |
| 422 | O3‐13‐04: Genome‐wide rare variant analysis identifies candidate genes significantly associated with composite scores for memory | 0.5 | 1 | Citations (PDF) |
| 423 | O4‐12‐06: The Alzheimer's metabolome: Identification of novel markers and treatment targets | 0.5 | 0 | Citations (PDF) |
| 424 | P4‐195: Pathway‐based gene analysis identifies vegfa as a gene associated with cerebral blood flow in Alzheimer's disease | 0.5 | 0 | Citations (PDF) |
| 425 | APOE genotype and neuroimaging markers of Alzheimer's disease: systematic review and meta-analysis | 6.3 | 148 | Citations (PDF) |
| 426 | Cortical surface biomarkers for predicting cognitive outcomes using group l2,1 norm | 3.4 | 48 | Citations (PDF) |
| 427 | Decreased Cerebral Blood Flow in Chronic Pediatric Mild TBI: An MRI Perfusion Study | 2.0 | 73 | Citations (PDF) |
| 428 | Protective variant for hippocampal atrophy identified by whole exome sequencing | 6.6 | 51 | Citations (PDF) |
| 429 | Common genetic variants influence human subcortical brain structures | 37.9 | 903 | Citations (PDF) |
| 430 | 2014 Update of the Alzheimer's Disease Neuroimaging Initiative: A review of papers published since its inception | 0.5 | 325 | Citations (PDF) |
| 431 | Impact of the Alzheimer's Disease Neuroimaging Initiative, 2004 to 2014 | 0.5 | 233 | Citations (PDF) |
| 432 | The Alzheimer's Disease Neuroimaging Initiative 2 Biomarker Core: A review of progress and plans | 0.5 | 98 | Citations (PDF) |
| 433 | Genetic studies of quantitative MCI and AD phenotypes in ADNI: Progress, opportunities, and plans | 0.5 | 304 | Citations (PDF) |
| 434 | Hippocampal transcriptome-guided genetic analysis of correlated episodic memory phenotypes in Alzheimer's disease | 2.3 | 26 | Citations (PDF) |
| 435 | Antiphospholipid autoantibodies as blood biomarkers for detection of early stage Alzheimer’s disease | 3.1 | 20 | Citations (PDF) |
| 436 | GWAS of longitudinal amyloid accumulation on18F-florbetapir PET in Alzheimer’s disease implicates microglial activation geneIL1RAPBrain, 2015, 138, 3076-3088 | 8.4 | 144 | Citations (PDF) |
| 437 | Partial volume correction in quantitative amyloid imaging | 4.4 | 246 | Citations (PDF) |
| 438 | Prospective assessment of white matter integrity in adult stem cell transplant recipients | 2.1 | 24 | Citations (PDF) |
| 439 | Functional neuroanatomical correlates of episodic memory impairment in early phase psychosis | 2.1 | 34 | Citations (PDF) |
| 440 | A novel Alzheimer disease locus located near the gene encoding tau protein | 7.8 | 317 | Citations (PDF) |
| 441 | Association of cancer history with Alzheimer's disease onset and structural brain changes | 2.8 | 53 | Citations (PDF) |
| 442 | P3‐018: INFLUENCE OF RARE PSEN1 VARIANTS ON QUANTITATIVE STRUCTURAL IMAGING AND CSF PHENOTYPES IN LATE ONSET ALZHEIMER'S DISEASE | 0.5 | 0 | Citations (PDF) |
| 443 | Transcriptome-guided amyloid imaging genetic analysis via a novel structured sparse learning algorithm | 4.7 | 69 | Citations (PDF) |
| 444 | Effects of Multiple Genetic Loci on Age at Onset in Late-Onset Alzheimer Disease | 17.6 | 191 | Citations (PDF) |
| 445 | Longitudinal assessment of cognitive changes associated with adjuvant treatment for breast cancer: the impact of APOE
and smoking | 3.0 | 81 | Citations (PDF) |
| 446 | The ENIGMA Consortium: large-scale collaborative analyses of neuroimaging and genetic data | 2.1 | 840 | Citations (PDF) |
| 447 | Computational genetics analysis of grey matter density in Alzheimer’s disease | 3.6 | 8 | Citations (PDF) |
| 448 | Identifying the Neuroanatomical Basis of Cognitive Impairment in Alzheimer's Disease by Correlation- and Nonlinearity-Aware Sparse Bayesian Learning | 7.8 | 54 | Citations (PDF) |
| 449 | Association of plasma and cortical amyloid beta is modulated by APOE ε4 status | 0.5 | 45 | Citations (PDF) |
| 450 | Translational research on aging: clinical epidemiology as a bridge between the sciences | 4.0 | 12 | Citations (PDF) |
| 451 | Effects of traumatic brain injury and posttraumatic stress disorder on Alzheimer's disease in veterans, using the Alzheimer's Disease Neuroimaging Initiative | 0.5 | 65 | Citations (PDF) |
| 452 | IC‐P‐172: GENOME‐WIDE PROTEIN INTERACTION GUIDED EPISTATIC ANALYSIS ON MEMORY PERFORMANCE: AN ADNI STUDY | 0.5 | 0 | Citations (PDF) |
| 453 | O3‐03‐02: TWO‐YEAR LONGITUDINAL CHANGE IN AMYLOID DEPOSITION, GLUCOSE METABOLISM, AND HIPPOCAMPAL ATROPHY IN ADNI‐2 PARTICIPANTS: RELATION TO GENETIC RISK | 0.5 | 1 | Citations (PDF) |
| 454 | IC‐P‐173: EFFECTS OF NEWLY IDENTIFIED TOP AD CANDIDATE GENES ON MEMORY PERFORMANCE: SNP, GENE, AND EPISTASIS ANALYSES IN ADNI | 0.5 | 0 | Citations (PDF) |
| 455 | IC‐P‐177: GENETIC FINDINGS USING ADNI MULTIMODAL QUANTITATIVE PHENOTYPES: A REVIEW OF PAPERS PUBLISHED IN 2013 | 0.5 | 0 | Citations (PDF) |
| 456 | P3‐102: VISUAL AND AUDITORY CHANGES ARE ASSOCIATED WITH NEUROIMAGING BIOMARKERS DURING PRODROMAL STAGES OF ALZHEIMER'S DISEASE | 0.5 | 0 | Citations (PDF) |
| 457 | P1‐230: EFFECTS OF NEWLY IDENTIFIED TOP AD CANDIDATE GENES ON MEMORY PERFORMANCE: SNP, GENE, AND EPISTASIS ANALYSES IN ADNI | 0.5 | 0 | Citations (PDF) |
| 458 | IC‐P‐094: ALTERED FMRI ACTIVATION PATTERN DURING VISUAL SCENE ENCODING IN AFFECTED AND NON‐AFFECTED CARRIERS OF PSEN1 AND APP MUTATIONS | 0.5 | 1 | Citations (PDF) |
| 459 | IC‐P‐095: TWO‐YEAR LONGITUDINAL CHANGE IN AMYLOID DEPOSITION, GLUCOSE METABOLISM, AND HIPPOCAMPAL ATROPHY IN ADNI‐2 PARTICIPANTS: RELATION TO GENETIC RISK | 0.5 | 0 | Citations (PDF) |
| 460 | IC‐P‐097: VISUAL AND AUDITORY CHANGES ARE ASSOCIATED WITH NEUROIMAGING BIOMARKERS DURING PRODROMAL STAGES OF ALZHEIMER'S DISEASE | 0.5 | 0 | Citations (PDF) |
| 461 | O1‐01‐03: COMPARATIVE ANALYSIS OF PIB IN VIVO WITH 6‐CN‐PIB AND AB‐IMMUNOHISTOCHEMISTRY POSTMORTEM IN FAMILIAL ALZHEIMER'S DISEASE ASSOCIATED WITH THE PSEN1 I229F MUTATION | 0.5 | 0 | Citations (PDF) |
| 462 | P4‐105: ALTERED FMRI ACTIVATION PATTERN DURING VISUAL SCENE ENCODING IN AFFECTED AND NON‐AFFECTED CARRIERS OF PSEN1 AND APP MUTATIONS | 0.5 | 0 | Citations (PDF) |
| 463 | IC‐P‐174: RARE VARIANT IN PLD3 IS ASSOCIATED WITH ALZHEIMER'S PATTERN OF NEURODEGENERATIVE CHANGES | 0.5 | 0 | Citations (PDF) |
| 464 | P3‐024: NEXT‐GENERATION SEQUENCING OF THE BCHE LOCUS IDENTIFIES A FUNCTIONAL SNP ASSOCIATED WITH ALZHEIMER'S DISEASE BIOMARKERS AND AGE OF ONSET | 0.5 | 0 | Citations (PDF) |
| 465 | O2‐03‐01: INCREASED AMYLOID DEPOSITION IN OLDER ADULTS AT RISK FOR PROGRESSION TO ALZHEIMER'S DISEASE DUE TO GENETIC BACKGROUND AND/OR THE PRESENCE OF SIGNIFICANT MEMORY CONCERNS | 0.5 | 0 | Citations (PDF) |
| 466 | IC‐P‐096: INCREASED AMYLOID DEPOSITION IN OLDER ADULTS AT RISK FOR PROGRESSION TO ALZHEIMER'S DISEASE DUE TO GENETIC BACKGROUND AND/OR THE PRESENCE OF SIGNIFICANT MEMORY CONCERNS | 0.5 | 0 | Citations (PDF) |
| 467 | P1‐213: GENOME‐WIDE PROTEIN INTERACTION‐GUIDED EPISTATIC ANALYSIS ON MEMORY PERFORMANCE: AN ADNI STUDY | 0.5 | 0 | Citations (PDF) |
| 468 | IC‐P‐032: COMPARATIVE ANALYSIS OF PIB IN VIVO WITH 6‐CN‐PIB AND Aβ‐IMMUNOHISTOCHEMISTRY POSTMORTEM IN FAMILIAL ALZHEIMER DISEASE ASSOCIATED WITH THE PSEN1 I229F MUTATION | 0.5 | 0 | Citations (PDF) |
| 469 | P3‐017: ASSOCIATION ANALYSIS OF RARE VARIANTS NEAR THE APOE REGION WITH CEREBROSPINAL FLUID (CSF) BIOMARKERS OF ALZHEIMER'S DISEASE | 0.5 | 0 | Citations (PDF) |
| 470 | P1‐141: GENETIC FINDINGS USING ADNI MULTIMODAL QUANTITATIVE PHENOTYPES: A REVIEW OF PAPERS PUBLISHED IN 2013 | 0.5 | 0 | Citations (PDF) |
| 471 | IC‐P‐024: BIN1 AND CR1 VARIANTS AFFECT COGNITIVE PERFORMANCE, NEURODEGENERATION, AND BRAIN AMYLOIDOSIS IN ADNI SUBJECTS | 0.5 | 0 | Citations (PDF) |
| 472 | IC‐P‐106: LONGITUDINAL RATES OF ATROPHY IN FAMILIAL ALZHEIMER'S DISEASE | 0.5 | 0 | Citations (PDF) |
| 473 | IC‐P‐138: POSTERIOR CEREBRAL ATROPHY ASSOCIATED WITH THE PSEN1 I229F MUTATION | 0.5 | 0 | Citations (PDF) |
| 474 | P4‐083: THE COGNITIVE CHANGE INDEX AS A MEASURE OF SUBJECTIVE COGNITIVE DECLINE AND INFORMANT PERCEPTION: RELATION TO TEST PERFORMANCE | 0.5 | 0 | Citations (PDF) |
| 475 | P4‐146: POSTERIOR CEREBRAL ATROPHY ASSOCIATED WITH THE PSEN1 I229F MUTATION | 0.5 | 0 | Citations (PDF) |
| 476 | P4‐237: WHOLE GENE‐BASED ASSOCIATION OF BASELINE PLASMA HOMOCYSTEINE IN THE ADNI‐1 COHORT | 0.5 | 0 | Citations (PDF) |
| 477 | FASTKD2 is associated with memory and hippocampal structure in older adults | 7.8 | 34 | Citations (PDF) |
| 478 | Altered Cerebral Blood Flow One Month after Systemic Chemotherapy for Breast Cancer: A Prospective Study Using Pulsed Arterial Spin Labeling MRI Perfusion | 2.3 | 57 | Citations (PDF) |
| 479 | Chemotherapy-induced amenorrhea: a prospective study of brain activation changes and neurocognitive correlates | 2.1 | 36 | Citations (PDF) |
| 480 | Frontal gray matter reduction after breast cancer chemotherapy and association with executive symptoms: A replication and extension study | 4.5 | 208 | Citations (PDF) |
| 481 | IC‐O1–03: Hippocampal transcriptome‐guided gene‐gene interaction of memory phenotype in MCI and Alzheimer's disease | 0.5 | 0 | Citations (PDF) |
| 482 | Cognitive Effects of Cancer and Its Treatments at the Intersection of Aging: What Do We Know; What Do We Need to Know? | 1.9 | 136 | Citations (PDF) |
| 483 | Regional variability of imaging biomarkers in autosomal dominant Alzheimer’s disease | 7.5 | 383 | Citations (PDF) |
| 484 | Alterations in brain structure related to breast cancer and its treatment: chemotherapy and other considerations | 2.1 | 75 | Citations (PDF) |
| 485 | Neuroimaging biomarkers and cognitive function in non-CNS cancer and its treatment: Current status and recommendations for future research | 2.1 | 48 | Citations (PDF) |
| 486 | Genome-wide scan of healthy human connectome discovers
SPON1
gene variant influencing dementia severity | 7.5 | 155 | Citations (PDF) |
| 487 | The Alzheimer's Disease Neuroimaging Initiative: A review of papers published since its inception | 0.5 | 671 | Citations (PDF) |
| 488 | Increased CNV-Region deletions in mild cognitive impairment (MCI) and Alzheimer's disease (AD) subjects in the ADNI sample | 2.8 | 24 | Citations (PDF) |
| 489 | Visual contrast sensitivity in Alzheimer’s disease, mild cognitive impairment, and older adults with cognitive complaints | 3.4 | 154 | Citations (PDF) |
| 490 | Subscale Validation of the Neuropsychiatric Inventory Questionnaire: Comparison of Alzheimer's Disease Neuroimaging Initiative and National Alzheimer's Coordinating Center Cohorts | 1.7 | 50 | Citations (PDF) |
| 491 | Increased working memory-related brain activity in middle-aged women with cognitive complaints | 3.4 | 59 | Citations (PDF) |
| 492 | Robust estimation of fractal measures for characterizing the structural complexity of the human brain: Optimization and reproducibility | 4.4 | 37 | Citations (PDF) |
| 493 | Functional microRNAs in Alzheimer’s disease and cancer: differential regulation of common mechanisms and pathway | 2.3 | 72 | Citations (PDF) |
| 494 | Whole-exome sequencing and imaging genetics identify functional variants for rate of change in hippocampal volume in mild cognitive impairment | 7.8 | 90 | Citations (PDF) |
| 495 | Effect of Complement CR1 on Brain Amyloid Burden During Aging and Its Modification by APOE Genotype | 5.4 | 81 | Citations (PDF) |
| 496 | Neuroimaging and Other Biomarkers for Alzheimer's Disease: The Changing Landscape of Early Detection | 11.7 | 132 | Citations (PDF) |
| 497 | Neuroimaging, Cancer, and Cognition: State of the Knowledge | 1.7 | 25 | Citations (PDF) |
| 498 | The pattern of atrophy in familial Alzheimer disease | 1.0 | 80 | Citations (PDF) |
| 499 | Impaired default network functional connectivity in autosomal dominant Alzheimer disease | 1.0 | 191 | Citations (PDF) |
| 500 | Neuroimaging Biomarkers of Neurodegenerative Diseases and Dementia | 1.7 | 138 | Citations (PDF) |
| 501 | Influence of TSPO Genotype on 11C-PBR28 Standardized Uptake Values | 5.1 | 64 | Citations (PDF) |
| 502 | Altered Default Mode Network Connectivity in Older Adults with Cognitive Complaints and Amnestic Mild Cognitive Impairment | 2.6 | 159 | Citations (PDF) |
| 503 | Cholinergic Enhancement of Brain Activation in Mild Cognitive Impairment during Episodic Memory Encoding | 2.4 | 30 | Citations (PDF) |
| 504 | The role of apolipoprotein E (APOE) genotype in early mild cognitive impairment (E-MCI) | 3.9 | 135 | Citations (PDF) |
| 505 | Gene-based GWAS and biological pathway analysis of the resilience of executive functioning | 2.1 | 36 | Citations (PDF) |
| 506 | Genetic analysis of quantitative phenotypes in AD and MCI: imaging, cognition and biomarkers | 2.1 | 177 | Citations (PDF) |
| 507 | APOE and BCHE as modulators of cerebral amyloid deposition: a florbetapir PET genome-wide association study | 7.8 | 197 | Citations (PDF) |
| 508 | Influence of Genetic Variation on Plasma Protein Levels in Older Adults Using a Multi-Analyte Panel | 2.3 | 54 | Citations (PDF) |
| 509 | Characterizing the Role of Brain Derived Neurotrophic Factor Genetic Variation in Alzheimer’s Disease Neurodegeneration | 2.3 | 55 | Citations (PDF) |
| 510 | Differences in Medication Use in the Alzheimerʼs Disease Neuroimaging Initiative | 3.2 | 20 | Citations (PDF) |
| 511 | Identifying disease sensitive and quantitative trait-relevant biomarkers from multidimensional heterogeneous imaging genetics data via sparse multimodal multitask learning | 4.7 | 125 | Citations (PDF) |
| 512 | Polymorphisms in the Brain-Derived Neurotrophic Factor Gene Influence Memory and Processing Speed One Month after Brain Injury | 3.6 | 82 | Citations (PDF) |
| 513 | Association of common genetic variants in GPCPD1 with scaling of visual cortical surface area in humans | 7.5 | 50 | Citations (PDF) |
| 514 | From phenotype to genotype: an association study of longitudinal phenotypic markers to Alzheimer's disease relevant SNPs | 4.7 | 68 | Citations (PDF) |
| 515 | Identifying quantitative trait loci via group-sparse multitask regression and feature selection: an imaging genetics study of the ADNI cohort | 4.7 | 169 | Citations (PDF) |
| 516 | Advanced cognitive training for breast cancer survivors: a randomized controlled trial | 2.3 | 213 | Citations (PDF) |
| 517 | The Alzheimer's Disease Neuroimaging Initiative: A review of papers published since its inception | 0.5 | 471 | Citations (PDF) |
| 518 | O2‐06‐01: Disrupted functional connectivity in autosomal dominant Alzheimer's disease: Preliminary findings from the DIAN study | 0.5 | 1 | Citations (PDF) |
| 519 | Identification of common variants associated with human hippocampal and intracranial volumes | 25.2 | 652 | Citations (PDF) |
| 520 | Novel late-onset Alzheimer disease loci variants associate with brain gene expression | 1.0 | 155 | Citations (PDF) |
| 521 | Selective changes in white matter integrity in MCI and older adults with cognitive complaints | 4.1 | 107 | Citations (PDF) |
| 522 | Genome-wide association study of Alzheimer's disease | 5.2 | 235 | Citations (PDF) |
| 523 | A large scale multivariate parallel ICA method reveals novel imaging–genetic relationships for Alzheimer's disease in the ADNI cohort | 4.4 | 120 | Citations (PDF) |
| 524 | Characteristics and variability of structural networks derived from diffusion tensor imaging | 4.4 | 123 | Citations (PDF) |
| 525 | Genetic architecture of resilience of executive functioning | 2.1 | 25 | Citations (PDF) |
| 526 | Genome-wide pathway analysis of memory impairment in the Alzheimer’s Disease Neuroimaging Initiative (ADNI) cohort implicates gene candidates, canonical pathways, and networks | 2.1 | 59 | Citations (PDF) |
| 527 | Voxel and surface-based topography of memory and executive deficits in mild cognitive impairment and Alzheimer’s disease | 2.1 | 77 | Citations (PDF) |
| 528 | Dysexecutive and amnesic AD subtypes defined by single indicator and modern psychometric approaches: relationships with SNPs in ADNI | 2.1 | 16 | Citations (PDF) |
| 529 | Relationship between baseline brain metabolism measured using [18F]FDG PET and memory and executive function in prodromal and early Alzheimer’s disease | 2.1 | 51 | Citations (PDF) |
| 530 | Common folate gene variant, MTHFR C677T, is associated with brain structure in two independent cohorts of people with mild cognitive impairment | 3.3 | 38 | Citations (PDF) |
| 531 | Analysis of Copy Number Variation in Alzheimer’s Disease in a Cohort of Clinically Characterized and Neuropathologically Verified Individuals | 2.3 | 53 | Citations (PDF) |
| 532 | Development of CBT for chemotherapy‐related cognitive change: results of a waitlist control trial | 3.0 | 227 | Citations (PDF) |
| 533 | Multiple loci influencing hippocampal degeneration identified by genome scan | 6.6 | 64 | Citations (PDF) |
| 534 | Functional MRI of mild traumatic brain injury (mTBI): progress and perspectives from the first decade of studies | 2.1 | 142 | Citations (PDF) |
| 535 | Optimization of seed density in DTI tractography for structural networks | 2.2 | 64 | Citations (PDF) |
| 536 | Pathway analysis of genomic data: concepts, methods, and prospects for future development | 9.8 | 252 | Citations (PDF) |
| 537 | Genome-wide association identifies genetic variants associated with lentiform nucleus volume in N = 1345 young and elderly subjects | 2.1 | 28 | Citations (PDF) |
| 538 | Alterations in brain structure and function in breast cancer survivors: effect of post-chemotherapy interval and relation to oxidative DNA damage | 2.3 | 138 | Citations (PDF) |
| 539 | The Interleukin 3 Gene (IL3) Contributes to Human Brain Volume Variation by Regulating Proliferation and Survival of Neural Progenitors | 2.3 | 43 | Citations (PDF) |
| 540 | Voxelwise gene-wide association study (vGeneWAS): Multivariate gene-based association testing in 731 elderly subjects | 4.4 | 127 | Citations (PDF) |
| 541 | Regional reproducibility of pulsed arterial spin labeling perfusion imaging at 3T | 4.4 | 85 | Citations (PDF) |
| 542 | Alpha-2 adrenergic challenge with guanfacine one month after mild traumatic brain injury: Altered working memory and BOLD response | 1.1 | 66 | Citations (PDF) |
| 543 | Abnormal error-related antisaccade activation in premanifest and early manifest Huntington disease. | 1.6 | 20 | Citations (PDF) |
| 544 | Common variants at MS4A4/MS4A6E, CD2AP, CD33 and EPHA1 are associated with late-onset Alzheimer's disease | 25.2 | 1,876 | Citations (PDF) |
| 545 | Discovery and replication of dopamine-related gene effects on caudate volume in young and elderly populations (N=1198) using genome-wide search | 7.8 | 55 | Citations (PDF) |
| 546 | Structural and functional magnetic resonance imaging of autism spectrum disorders | 2.5 | 185 | Citations (PDF) |
| 547 | Genome-wide association study of CSF biomarkers Aβ
1-42
, t-tau, and p-tau
181p
in the ADNI cohort | 1.0 | 204 | Citations (PDF) |
| 548 | Regional gray matter correlates of perceived emotional intelligence | 2.7 | 47 | Citations (PDF) |
| 549 | Genome-wide association analysis of age-at-onset in Alzheimer's disease | 7.8 | 99 | Citations (PDF) |
| 550 | Amyloid pathway-based candidate gene analysis of [11C]PiB-PET in the Alzheimer’s Disease Neuroimaging Initiative (ADNI) cohort | 2.1 | 50 | Citations (PDF) |
| 551 | Comparison of vertical and horizontal saccade measures and their relation to gray matter changes in premanifest and manifest Huntington disease | 3.4 | 32 | Citations (PDF) |
| 552 | Cholinergic modulation of hippocampal activity during episodic memory encoding in postmenopausal women | 2.4 | 22 | Citations (PDF) |
| 553 | Comparison of Manual and Automated Determination of Hippocampal Volumes in MCI and Early AD | 2.1 | 76 | Citations (PDF) |
| 554 | Gray matter reduction associated with systemic chemotherapy for breast cancer: a prospective MRI study | 2.3 | 306 | Citations (PDF) |
| 555 | Genetic pathway‐based hierarchical clustering analysis of older adults with cognitive complaints and amnestic mild cognitive impairment using clinical and neuroimaging phenotypes | 1.5 | 33 | Citations (PDF) |
| 556 | A commonly carried allele of the obesity-related
FTO
gene is associated with reduced brain volume in the healthy elderly | 7.5 | 240 | Citations (PDF) |
| 557 | Sex-dependent association of common variants of microcephaly genes with brain structure | 7.5 | 120 | Citations (PDF) |
| 558 | Meta-analysis Confirms CR1, CLU, and PICALM as Alzheimer Disease Risk Loci and Reveals Interactions With APOE Genotypes | 6.8 | 407 | Citations (PDF) |
| 559 | Subjective rating of working memory is associated with frontal lobe volume in schizophrenia | 2.3 | 38 | Citations (PDF) |
| 560 | Voxelwise genome-wide association study (vGWAS) | 4.4 | 261 | Citations (PDF) |
| 561 | Genome-wide analysis reveals novel genes influencing temporal lobe structure with relevance to neurodegeneration in Alzheimer's disease | 4.4 | 146 | Citations (PDF) |
| 562 | Longitudinal MRI atrophy biomarkers: Relationship to conversion in the ADNI cohort | 3.4 | 268 | Citations (PDF) |
| 563 | Association between mitochondrial DNA variations and Alzheimer's disease in the ADNI cohort | 3.4 | 107 | Citations (PDF) |
| 564 | In-Home Virtual Reality Videogame Telerehabilitation in Adolescents With Hemiplegic Cerebral Palsy | 1.9 | 257 | Citations (PDF) |
| 565 | Clinical core of the Alzheimer's disease neuroimaging initiative: Progress and plans | 0.5 | 494 | Citations (PDF) |
| 566 | The Alzheimer's Disease Neuroimaging Initiative: Progress report and future plans | 0.5 | 543 | Citations (PDF) |
| 567 | Alzheimer's Disease Neuroimaging Initiative biomarkers as quantitative phenotypes: Genetics core aims, progress, and plans | 0.5 | 443 | Citations (PDF) |
| 568 | IC‐01‐04: Neuroinflammation and amyloid deposition: Concurrent [11C]PBR28 and [11C]PIB PET imaging in patients with Alzheimer's disease, mild cognitive impairment, and older adults with cognitive complaints | 0.5 | 3 | Citations (PDF) |
| 569 | O3‐03‐01: Genome‐wide association study of CSF biomarkers amyloid beta 1‐42, tau and tau phosphorylated at threonine 181 in the ADNI cohort | 0.5 | 1 | Citations (PDF) |
| 570 | O3‐06‐01: Association analysis of candidate SNPs on hippocampal volume and shape in mild cognitive impairment and older adults with cognitive complaints | 0.5 | 1 | Citations (PDF) |
| 571 | Whole genome association study of brain-wide imaging phenotypes for identifying quantitative trait loci in MCI and AD: A study of the ADNI cohort | 4.4 | 382 | Citations (PDF) |
| 572 | Apolipoprotein E (APOE) genotype has dissociable effects on memory and attentional–executive network function in Alzheimer’s disease | 7.5 | 235 | Citations (PDF) |
| 573 | Genome-wide association with MRI atrophy measures as a quantitative trait locus for Alzheimer's disease | 7.8 | 148 | Citations (PDF) |
| 574 | Hippocampal Atrophy as a Quantitative Trait in a Genome-Wide Association Study Identifying Novel Susceptibility Genes for Alzheimer's Disease | 2.3 | 348 | Citations (PDF) |
| 575 | Differential Memory Test Sensitivity for Diagnosing Amnestic Mild Cognitive Impairment and Predicting Conversion to Alzheimer's Disease | 1.6 | 232 | Citations (PDF) |
| 576 | Fourier method for large-scale surface modeling and registration | 1.9 | 28 | Citations (PDF) |
| 577 | Parametric surface modeling and registration for comparison of manual and automated segmentation of the hippocampus | 2.5 | 34 | Citations (PDF) |
| 578 | Decreased cancer survival in individuals separated at time of diagnosis | 4.0 | 40 | Citations (PDF) |
| 579 | Short Term Exposure to a Violent Video Game Induces Changes in Frontolimbic Circuitry in Adolescents | 2.1 | 64 | Citations (PDF) |
| 580 | Judgment in Older Adults with Normal Cognition, Cognitive Complaints, MCI, and Mild AD: Relation to Regional Frontal Gray Matter | 2.1 | 20 | Citations (PDF) |
| 581 | Fully automated synthesis and initial PET evaluation of [11C]PBR28 | 2.0 | 42 | Citations (PDF) |
| 582 | Lack of relationship between psychological denial and unawareness of illness in schizophrenia-spectrum disorders | 3.1 | 18 | Citations (PDF) |
| 583 | Apathy and the processing of novelty in schizophrenia | 2.3 | 16 | Citations (PDF) |
| 584 | Verbal fluency performance in amnestic MCI and older adults with cognitive complaints | 0.4 | 212 | Citations (PDF) |
| 585 | Nicotinic Versus Muscarinic Blockade Alters Verbal Working Memory-Related Brain Activity in Older Women | 1.7 | 35 | Citations (PDF) |
| 586 | Age-related deficits in fronto-temporal connections in schizophrenia: A diffusion tensor imaging study | 2.3 | 86 | Citations (PDF) |
| 587 | A Survey of Neuropsychologists' Practices and Perspectives Regarding the Assessment of Judgment Ability | 1.9 | 44 | Citations (PDF) |
| 588 | Single nucleotide polymorphisms in ANKK1 and the dopamine D2 receptor gene affect cognitive outcome shortly after traumatic brain injury: A replication and extension study | 1.6 | 81 | Citations (PDF) |
| 589 | A New Measure of Visual Location Learning and Memory: Development and Psychometric Properties for the Brown Location Test (BLT) | 2.7 | 33 | Citations (PDF) |
| 590 | Hippocampal Volume and Shape Analysis in an Older Adult Population | 2.7 | 31 | Citations (PDF) |
| 591 | Brain Structure and Function Differences in Monozygotic Twins: Possible Effects of Breast Cancer Chemotherapy | 16.9 | 264 | Citations (PDF) |
| 592 | Cancer chemotherapy impairs contextual but not cue-specific fear memory | 2.2 | 85 | Citations (PDF) |
| 593 | The Memory and Aging Telephone Screen: Development and preliminary validation 2007, 3, 109-121 | | 28 | Citations (PDF) |
| 594 | Judgment in older adults: Development and psychometric evaluation of the Test of Practical Judgment (TOP-J) | 1.0 | 48 | Citations (PDF) |
| 595 | Event-Related Functional Magnetic Resonance Imaging of Response Inhibition in Obsessive-Compulsive Disorder | 5.4 | 167 | Citations (PDF) |
| 596 | Candidate mechanisms for chemotherapy-induced cognitive changes | 60.7 | 873 | Citations (PDF) |
| 597 | Cavum septum pellucidum in schizophrenia: Clinical and neuropsychological correlates | 1.9 | 42 | Citations (PDF) |
| 598 | A Novel Surface Registration Algorithm With Biomedical Modeling Applications | 2.1 | 19 | Citations (PDF) |
| 599 | Clinical Use of Functional Magnetic Resonance Imaging: Reflections on the New CPT Codes | 3.4 | 32 | Citations (PDF) |
| 600 | Cognitive function in breast cancer patients prior to adjuvant treatment | 2.3 | 320 | Citations (PDF) |
| 601 | Self- and informant reports of executive function on the BRIEF-A in MCI and older adults with cognitive complaints | 0.4 | 143 | Citations (PDF) |
| 602 | Regionally specific atrophy of the corpus callosum in AD, MCI and cognitive complaints | 3.4 | 108 | Citations (PDF) |
| 603 | Functional magnetic resonance imaging of executive control in bipolar disorder | 1.5 | 45 | Citations (PDF) |
| 604 | The fornix and mammillary bodies in older adults with Alzheimer's disease, mild cognitive impairment, and cognitive complaints: A volumetric MRI study | 1.9 | 107 | Citations (PDF) |
| 605 | Older adults with cognitive complaints show brain atrophy similar to that of amnestic MCI | 1.0 | 545 | Citations (PDF) |
| 606 | Functional magnetic resonance imaging of the primary somatosensory cortex in piglets | 0.0 | 10 | Citations (PDF) |
| 607 | Regional brain atrophy in cognitively intact adults with a single APOE ε4 allele | 1.0 | 156 | Citations (PDF) |
| 608 | Mechanisms of Working Memory Dysfunction after Mild and Moderate TBI: Evidence from Functional MRI and Neurogenetics | 3.6 | 252 | Citations (PDF) |
| 609 | Increased Brain Activation During Working Memory in Cognitively Intact Adults With the APOE ε4 Allele | 8.8 | 137 | Citations (PDF) |
| 610 | Quality of Life of Long-Term Survivors of Breast Cancer and Lymphoma Treated With Standard-Dose Chemotherapy or Local Therapy | 16.9 | 120 | Citations (PDF) |
| 611 | A surface-based approach for classification of 3D neuroanatomic structures | 0.6 | 86 | Citations (PDF) |
| 612 | Brain activation patterns associated with working memory in relapsing-remitting MS | 1.0 | 114 | Citations (PDF) |
| 613 | Working memory deficits after traumatic brain injury: catecholaminergic mechanisms and prospects for treatment — a review | 1.6 | 124 | Citations (PDF) |
| 614 | Cholinergic enhancement of frontal lobe activity in mild cognitive impairmentBrain, 2004, 127, 1574-1583 | 8.4 | 215 | Citations (PDF) |
| 615 | Cognitive effects of cytotoxic cancer chemotherapy: Predisposing risk factors and potential treatments | 5.3 | 56 | Citations (PDF) |
| 616 | Executive dysfunction in attention-deficit/hyperactivity disorder: cognitive and neuroimaging findings | 2.1 | 118 | Citations (PDF) |
| 617 | Neuropsychological impairment in borderline personality disorder | 2.1 | 42 | Citations (PDF) |
| 618 | Contribution of Organizational Strategy to Verbal Learning and Memory in Adults With Attention-Deficit/Hyperactivity Disorder. | 1.6 | 48 | Citations (PDF) |
| 619 | Sex differences in semantic language processing: A functional MRI study | 1.8 | 132 | Citations (PDF) |
| 620 | The relationship of APOE genotype to neuropsychological performance in long-term cancer survivors treated with standard dose chemotherapy | 3.0 | 345 | Citations (PDF) |
| 621 | Chronic deep brain stimulation for the treatment of tremor in multiple sclerosis: review and case reports | 6.3 | 91 | Citations (PDF) |
| 622 | Mild cognitive impairment: Conceptual issues and structural and functional brain correlates | 1.7 | 83 | Citations (PDF) |
| 623 | Intact Motor Imagery in Chronic Upper Limb Hemiplegics: Evidence for Activity-Independent Action Representations | 2.2 | 153 | Citations (PDF) |
| 624 | Executive dysfunction following traumatic brain injury: Neural substrates and treatment strategies | 1.3 | 252 | Citations (PDF) |
| 625 | Functional magnetic resonance imaging: Emerging clinical applications | 5.3 | 7 | Citations (PDF) |
| 626 | Differential Working Memory Load Effects after Mild Traumatic Brain Injury | 4.4 | 474 | Citations (PDF) |
| 627 | Similarities and Differences in Semantic and Phonological Processing with Age Patterns of Functional MRI Activation | 1.6 | 19 | Citations (PDF) |
| 628 | Neuroimaging Findings in Mild Traumatic Brain Injury * | 1.0 | 136 | Citations (PDF) |
| 629 | Specific Frontal Lobe Subregions Correlated With Unawareness of Illness in Schizophrenia | 2.3 | 103 | Citations (PDF) |
| 630 | Deep brain stimulation in neuropsychiatric disorders | 5.3 | 13 | Citations (PDF) |
| 631 | The neuropsychology of multiple sclerosis: Contributions of neuroimaging research | 5.3 | 6 | Citations (PDF) |
| 632 | Cognitive Effects of Standard-Dose Chemotherapy in Patients with Cancer | 1.6 | 195 | Citations (PDF) |
| 633 | Smaller Brain Size Associated With Unawareness of Illness in Patients With Schizophrenia | 8.8 | 65 | Citations (PDF) |
| 634 | Data mining in brain imaging | 1.6 | 59 | Citations (PDF) |
| 635 | The Relationship between fMRI Activation and Cerebral Atrophy: Comparison of Normal Aging and Alzheimer Disease | 4.4 | 153 | Citations (PDF) |
| 636 | 10.1016/s1084-3612(03)00055-8 | 0.0 | 1 | Citations (PDF) |
| 637 | Age-related fMRI activation differences during semantic decision making in young and elderly adults | 0.4 | 0 | Citations (PDF) |
| 638 | Brain activation during working memory 1 month after mild traumatic brain injury | 1.0 | 464 | Citations (PDF) |
| 639 | Neuropsychological Correlates of Methylphenidate Treatment in Adult ADHD With and Without Depression | 0.4 | 62 | Citations (PDF) |
| 640 | Functional MRI localisation of central nervous system regions associated with volitional inspiration in humans | 3.4 | 141 | Citations (PDF) |
| 641 | Neuropsychological Correlates of Methylphenidate Treatment in Adult ADHD With and Without Depression | 0.4 | 26 | Citations (PDF) |
| 642 | Functional differentiation of medial temporal and frontal regions involved in processing novel and familiar words: an fMRI studyBrain, 1999, 122, 1963-1971 | 8.4 | 129 | Citations (PDF) |
| 643 | Hippocampal Volume Reduction in Schizophrenia as Assessed by Magnetic Resonance Imaging | 12.7 | 718 | Citations (PDF) |
| 644 | Hippocampal volume reduction in schizophrenia as assessed by magnetic resonance imaging: A meta-analytic study | 2.3 | 6 | Citations (PDF) |
| 645 | Metamemory in Temporal Lobe Epilepsy | 3.6 | 10 | Citations (PDF) |
| 646 | Temporal Lobectomy for Refractory Epilepsy | 16.5 | 242 | Citations (PDF) |
| 647 | Proton Spectroscopy in Asymptomatic HIV-Infected Adults: Initial Results in a Prospective Cohort Study | 0.3 | 42 | Citations (PDF) |
| 648 | Cognitive functioning and neuroanatomic volume measures in schizophrenia. | 1.6 | 36 | Citations (PDF) |
| 649 | Neural organization of material-specific memory functions in temporal lobe epilepsy patients as assessed by the intracarotid amobarbital test. | 1.6 | 54 | Citations (PDF) |
| 650 | Language Before and After Temporal Lobectomy: Specificity of Acute Changes and Relation to Early Risk Factors | 4.4 | 151 | Citations (PDF) |
| 651 | Comparison of Mesial Versus Neocortical Onset Temporal Lobe Seizures: Neurodiagnostic Findings and Surgical Outcome | 4.4 | 98 | Citations (PDF) |
| 652 | Normative neuropsychological test performance: effects of age, education, gender and ethnicity | 1.9 | 97 | Citations (PDF) |
| 653 | Reading on the Wide Range Achievement Test-Revised and parental education as predictors of IQ: comparison with the Barona formula | 0.4 | 67 | Citations (PDF) |
| 654 | Occupational outcome after temporal lobectomy for refractory epilepsy | 1.0 | 118 | Citations (PDF) |
| 655 | Reading on the Wide Range Achievement Test-Revised and parental education as predictors of IQ: comparison with the Barona formula | 0.4 | 5 | Citations (PDF) |
| 656 | Neural organization of material-specific memory functions in temporal lobe epilepsy patients as assessed by the intracarotid amobarbital test. | 1.6 | 8 | Citations (PDF) |
| 657 | Multi-Modal Assessment in Alzheimer's Disease ADL in Relation to PET, MRI and Neuropsychology | 0.6 | 3 | Citations (PDF) |
| 658 | Neuropsychological Deficits in Neuroleptic Naive Patients With First-Episode Schizophrenia | 12.7 | 1,033 | Citations (PDF) |
| 659 | Predictors of outcome after anterior temporal lobectomy | 1.0 | 117 | Citations (PDF) |
| 660 | Unilateral Hemispheric Memory and Hippocampal Neuronal Density in Temporal Lobe Epilepsy | 2.0 | 44 | Citations (PDF) |
| 661 | Unilateral Hemispheric Memory and Hippocampal Neuronal Density in Temporal Lobe Epilepsy | 2.0 | 2 | Citations (PDF) |
| 662 | A noninvasive protocol for anterior temporal lobectomy | 1.0 | 132 | Citations (PDF) |
| 663 | Relations among clinical scales in schizophrenia | 8.8 | 153 | Citations (PDF) |
| 664 | Longitudinal evaluation of neuropsychological function in homosexual men with HIV infection: 18-month follow-up | 2.3 | 46 | Citations (PDF) |
| 665 | Acute effect of anterior temporal lobectomy on musical processing | 1.7 | 48 | Citations (PDF) |
| 666 | Comparison of two short forms of the Wisconsin Card Sorting Test | 0.4 | 49 | Citations (PDF) |
| 667 | Neuropsychological Function in Schizophrenia | 12.7 | 1,109 | Citations (PDF) |
| 668 | Comparison of two short forms of the Wisconsin Card Sorting Test | 0.4 | 3 | Citations (PDF) |
| 669 | Comparison of two short forms of the Wisconsin Card Sorting Test | 0.4 | 2 | Citations (PDF) |
| 670 | Neurobehavioral Studies in Schizophrenia: Implications for Regional Brain Dysfunction | 3.9 | 16 | Citations (PDF) |
| 671 | Characterization of neuropsychological dysfunction in schizophrenia: Relation to clinical subtypes and positive and negative features | 0.4 | 2 | Citations (PDF) |
| 672 | Acute naming deficits following dominant temporal lobectomy | 1.0 | 114 | Citations (PDF) |
| 673 | Neurological and neuropshychological manifestations of HIV-1 infection: Association with AIDS-related complex but not asymptomatic HIV-1 infection | 6.6 | 227 | Citations (PDF) |
| 674 | Memory deficits before and after temporal lobectomy: Effect of laterality and age of onset | 0.9 | 175 | Citations (PDF) |
| 675 | Neuropsychological functioning in hemiparkinsonism | 0.9 | 67 | Citations (PDF) |
| 676 | Memory during subclinical hippocampal seizures | 1.0 | 45 | Citations (PDF) |
| 677 | Neurological complications of human immunodeficiency virus infection in patients with lymphadenopathy syndrome | 6.6 | 124 | Citations (PDF) |
| 678 | Neurological symptoms and neuropsychological abnormalities in lymphadenopathy syndrome | 6.6 | 19 | Citations (PDF) |
| 679 | Neuropsychological Assessment of Neuropsychiatric Disorders | 8.8 | 1 | Citations (PDF) |
| 680 | Regional Brain Function in Schizophrenia | 12.7 | 211 | Citations (PDF) |
| 681 | Clinical Significance of Sleep Apnea in the Elderly | 3.2 | 80 | Citations (PDF) |
| 682 | Dementia of Parkinson's Disease and Alzheimer's Disease: Is There a Difference? | 2.9 | 13 | Citations (PDF) |
| 683 | Slowly progressive aphasia without generalized dementia: Studies with positron emission tomography | 6.6 | 172 | Citations (PDF) |
| 684 | On the nature and organization of the repressed | 0.4 | 8 | Citations (PDF) |
| 685 | miR-423-5p and miR-92a-3p in Alzheimer’s disease: relationship with pathology and cognition | 3.9 | 5 | Citations (PDF) |
| 686 | Associations of circulating c-reactive protein levels with central Alzheimer’s disease biomarkers | 3.3 | 2 | Citations (PDF) |
| 687 | Facets of language performance in early‐onset and late‐onset Alzheimer's disease dementia | 0.5 | 4 | Citations (PDF) |
| 688 | Validation of a MIND diet screener in older adults | 0.5 | 4 | Citations (PDF) |
| 689 | The Cognitive Change Index in the Alzheimer's Disease Research Center setting: Self‐ and informant‐ratings for perceived cognitive decline | 0.5 | 0 | Citations (PDF) |
| 690 | Mendelian Randomization Reveals Unidirectional Links Between Amyloid-β and Tau in Alzheimer’s Disease | 0.9 | 0 | Citations (PDF) |
| 691 | No significant associations between history of head injury and Alzheimer's disease fluid biomarkers in older adults | 2.6 | 0 | Citations (PDF) |
| 692 | Testing for Laterality Differences in Regional Brain Volumes | 12.7 | 0 | Citations (PDF) |
| 693 | Associations between subjective cognitive concern, brain network connectivity, and cognitive performance in cognitively normal older adults | 2.0 | 0 | Citations (PDF) |
| 694 | Heterogeneous patterns of cognitive decline in Alzheimer's disease across three domains of cognition | 2.6 | 0 | Citations (PDF) |
| 695 | Systems biology of Alzheimer’s Disease: a scoping review of key pathways and mechanisms | 14.1 | 5 | Citations (PDF) |
| 696 | Learning a continuous progression trajectory of amyloid in Alzheimer's disease | 2.4 | 0 | Citations (PDF) |
| 697 | Real‐world relationship between blood biomarker‐based PhenoAge, metformin, and Alzheimer's disease | 4.8 | 0 | Citations (PDF) |
| 698 | Integrating polygenic and transcriptional risk scores for detecting Alzheimer's disease | 0.5 | 1 | Citations (PDF) |
| 699 | Technology access and preferences for remote assessments at Alzheimer's Disease Research Centers | 0.5 | 0 | Citations (PDF) |
| 700 | Alzheimer’s Disease Genetic Risk Influences Recovery Among Individuals Receiving Traumatic Brain Injury Rehabilitation | 1.6 | 0 | Citations (PDF) |
| 701 | Individualized mapping of functional brain networks in older adulthood 0, 4, | | 0 | Citations (PDF) |
| 702 | Deep contrastive learning framework identifies cell‐type‐specific drug targets in Alzheimer's disease | 2.4 | 0 | Citations (PDF) |
